<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" xml:lang="en" dtd-version="1.4"><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">J Neurol</journal-id><journal-id journal-id-type="iso-abbrev">J Neurol</journal-id><journal-id journal-id-type="pmc-domain-id">365</journal-id><journal-id journal-id-type="pmc-domain">springeropen</journal-id><journal-title-group><journal-title>Journal of Neurology</journal-title></journal-title-group><issn pub-type="ppub">0340-5354</issn><issn pub-type="epub">1432-1459</issn><custom-meta-group><custom-meta><meta-name>pmc-is-collection-domain</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-collection-title</meta-name><meta-value>Springer</meta-value></custom-meta></custom-meta-group></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC11638321</article-id><article-id pub-id-type="pmcid-ver">PMC11638321.1</article-id><article-id pub-id-type="pmcaid">11638321</article-id><article-id pub-id-type="pmcaiid">11638321</article-id><article-id pub-id-type="pmid">39666175</article-id><article-id pub-id-type="doi">10.1007/s00415-024-12804-4</article-id><article-id pub-id-type="publisher-id">12804</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Original Communication</subject></subj-group></article-categories><title-group><article-title>Balance and gait disorders in de novo Parkinson&#8217;s disease: support for early rehabilitation</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0001-9021-9847</contrib-id><name name-style="western"><surname>Lindholm</surname><given-names initials="B">Beata</given-names></name><address><email>Beata.Lindholm@med.lu.se</email></address><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff2">2</xref><xref ref-type="aff" rid="Aff3">3</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Hagell</surname><given-names initials="P">Peter</given-names></name><xref ref-type="aff" rid="Aff4">4</xref><xref ref-type="aff" rid="Aff5">5</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Odin</surname><given-names initials="P">Per</given-names></name><xref ref-type="aff" rid="Aff2">2</xref><xref ref-type="aff" rid="Aff5">5</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Hansson</surname><given-names initials="O">Oskar</given-names></name><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Siennicki-Lantz</surname><given-names initials="A">Arkadiusz</given-names></name><xref ref-type="aff" rid="Aff3">3</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Elmst&#229;hl</surname><given-names initials="S">S&#246;lve</given-names></name><xref ref-type="aff" rid="Aff3">3</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Dahlin</surname><given-names initials="LB">Lars B.</given-names></name><xref ref-type="aff" rid="Aff6">6</xref><xref ref-type="aff" rid="Aff7">7</xref><xref ref-type="aff" rid="Aff8">8</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Franz&#233;n</surname><given-names initials="E">Erika</given-names></name><xref ref-type="aff" rid="Aff9">9</xref><xref ref-type="aff" rid="Aff10">10</xref></contrib><aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/012a77v79</institution-id><institution-id institution-id-type="GRID">grid.4514.4</institution-id><institution-id institution-id-type="ISNI">0000 0001 0930 2361</institution-id><institution>Cognitive Disorders Unit, Department of Clinical Sciences Malm&#246;, </institution><institution>Lund University, </institution></institution-wrap>205 02 Malm&#246;, Sweden </aff><aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/02z31g829</institution-id><institution-id institution-id-type="GRID">grid.411843.b</institution-id><institution-id institution-id-type="ISNI">0000 0004 0623 9987</institution-id><institution>Department of Neurology, Rehabilitation Medicine, Memory Disorders and Geriatrics, </institution><institution>Sk&#229;ne University Hospital Malm&#246;, </institution></institution-wrap>205 02 Malm&#246;, Sweden </aff><aff id="Aff3"><label>3</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/012a77v79</institution-id><institution-id institution-id-type="GRID">grid.4514.4</institution-id><institution-id institution-id-type="ISNI">0000 0001 0930 2361</institution-id><institution>Department of Clinical Sciences in Malm&#246;, Division of Geriatric Medicine, </institution><institution>Lund University, </institution></institution-wrap>Malm&#246;, Sweden </aff><aff id="Aff4"><label>4</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/00tkrft03</institution-id><institution-id institution-id-type="GRID">grid.16982.34</institution-id><institution-id institution-id-type="ISNI">0000 0001 0697 1236</institution-id><institution>The PRO&#8211;CARE Group, Faculty of Health Sciences, </institution><institution>Kristianstad University, </institution></institution-wrap>291 39 Kristianstad, Sweden </aff><aff id="Aff5"><label>5</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/012a77v79</institution-id><institution-id institution-id-type="GRID">grid.4514.4</institution-id><institution-id institution-id-type="ISNI">0000 0001 0930 2361</institution-id><institution>Division of Neurology, Department of Clinical Sciences Lund, </institution><institution>Lund University, </institution></institution-wrap>Lund, Sweden </aff><aff id="Aff6"><label>6</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/012a77v79</institution-id><institution-id institution-id-type="GRID">grid.4514.4</institution-id><institution-id institution-id-type="ISNI">0000 0001 0930 2361</institution-id><institution>Department Translational Medicine, </institution><institution>Lund University, </institution></institution-wrap>Malm&#246;, Sweden </aff><aff id="Aff7"><label>7</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/02z31g829</institution-id><institution-id institution-id-type="GRID">grid.411843.b</institution-id><institution-id institution-id-type="ISNI">0000 0004 0623 9987</institution-id><institution>Department of Hand Surgery, </institution><institution>Sk&#229;ne University Hospital, </institution></institution-wrap>Malm&#246;, Sweden </aff><aff id="Aff8"><label>8</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/05ynxx418</institution-id><institution-id institution-id-type="GRID">grid.5640.7</institution-id><institution-id institution-id-type="ISNI">0000 0001 2162 9922</institution-id><institution>Department of Biomedical and Clinical Sciences, </institution><institution>Link&#246;ping University, </institution></institution-wrap>Link&#246;ping, Sweden </aff><aff id="Aff9"><label>9</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/056d84691</institution-id><institution-id institution-id-type="GRID">grid.4714.6</institution-id><institution-id institution-id-type="ISNI">0000 0004 1937 0626</institution-id><institution>Division of Physiotherapy, Department of Neurobiology, Care Sciences and Society, </institution><institution>Karolinska Institutet, </institution></institution-wrap>Huddinge, Sweden </aff><aff id="Aff10"><label>10</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/00m8d6786</institution-id><institution-id institution-id-type="GRID">grid.24381.3c</institution-id><institution-id institution-id-type="ISNI">0000 0000 9241 5705</institution-id><institution>Medical Unit Allied Health Professionals, Women&#8217;s Health and Allied Health Professionals Theme, </institution><institution>Karolinska University Hospital, </institution></institution-wrap>Stockholm, Sweden </aff></contrib-group><pub-date pub-type="epub"><day>12</day><month>12</month><year>2024</year></pub-date><pub-date pub-type="ppub"><year>2025</year></pub-date><volume>272</volume><issue>1</issue><issue-id pub-id-type="pmc-issue-id">476987</issue-id><elocation-id>11</elocation-id><history><date date-type="received"><day>22</day><month>7</month><year>2024</year></date><date date-type="rev-recd"><day>1</day><month>10</month><year>2024</year></date><date date-type="accepted"><day>3</day><month>10</month><year>2024</year></date></history><pub-history><event event-type="pmc-release"><date><day>12</day><month>12</month><year>2024</year></date></event><event event-type="pmc-live"><date><day>14</day><month>12</month><year>2024</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2025-02-01 00:25:38.220"><day>01</day><month>02</month><year>2025</year></date></event></pub-history><permissions><copyright-statement>&#169; The Author(s) 2024</copyright-statement><copyright-year>2024</copyright-year><license><ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p><bold>Open Access</bold> This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>.</license-p></license></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="415_2024_Article_12804.pdf"/><abstract id="Abs1"><sec><title>Background</title><p id="Par1">Postural instability is considered a late complication of Parkinson&#8217;s disease (PD). However, growing evidence shows that balance and gait problems may occur early in the disease.</p></sec><sec><title>Objective</title><p id="Par2">To describe balance, gait, and falls/near falls in persons with newly diagnosed, untreated PD (&#8220;de novo&#8221;), and to compare this with persons with mild-moderate PD (Later PD). In addition, we evaluated differences relative to PD subtypes in de novo PD.</p></sec><sec><title>Methods</title><p id="Par3">De novo (<italic toggle="yes">n</italic>&#8201;=&#8201;54) and Later (<italic toggle="yes">n</italic>&#8201;=&#8201;58) PD were assessed regarding motor symptoms, balance, gait, and falls/near falls.</p></sec><sec><title>Results</title><p id="Par4">At least 25% of de novo PD had impaired reactive balance and/or comfortable gait speed&#8201;&#8804;&#8201;1.0&#160;m/s. At least 50% had abnormal dynamic balance. A third reported balance problems during dual-tasking. Five persons (9%) reported falls/near falls. The median (<italic toggle="yes">q</italic>1&#8211;<italic toggle="yes">q</italic>3) motor symptom score was 21 (14&#8211;28) in de novo PD and 13.5 (9&#8211;20) in Later PD (<italic toggle="yes">p</italic>&#8201;&lt;&#8201;0.001). Later PD performed worse on more balance-demanding tests and a higher percentage of individuals reported falls/near falls (<italic toggle="yes">p</italic>&#8201;&#8804;&#8201;0.048). De novo PIGD PD (<italic toggle="yes">n</italic>&#8201;=&#8201;10) exhibited worse motor symptoms, reactive and dynamic balance, gait speed, mobility, and freezing of gait as compared to the non-PIGD de novo PD (<italic toggle="yes">n</italic>&#8201;=&#8201;37) (<italic toggle="yes">p</italic>&#8201;&#8804;&#8201;0.049).</p></sec><sec><title>Conclusion</title><p id="Par5">Balance and gait were impaired in de novo PD and most pronounced in PIGD subtype. In addition, balance difficulties during dual-tasking and falls/near falls were evident during this early stage. The lower scores of motor symptoms in Later PD did not result in better mobility, balance, or less falls/near falls indicating that medications have less effect on these symptoms.</p></sec></abstract><kwd-group xml:lang="en"><title>Keywords</title><kwd>Parkinson&#8217;s disease</kwd><kwd>De novo</kwd><kwd>Balance and gait</kwd><kwd>Falls</kwd><kwd>Near falls</kwd><kwd>Neurorehabilitation</kwd></kwd-group><funding-group><award-group><funding-source><institution>Stoltz foundation</institution></funding-source></award-group></funding-group><funding-group><award-group><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100012558</institution-id><institution>Sk&#229;ne County Council's Research and Development Foundation</institution></institution-wrap></funding-source></award-group></funding-group><funding-group><award-group><funding-source><institution>The Erik Hardebos foundation</institution></funding-source></award-group></funding-group><funding-group><award-group><funding-source><institution>Kockska foundation</institution></funding-source></award-group></funding-group><funding-group><award-group><funding-source><institution>Neuro foundation</institution></funding-source></award-group></funding-group><funding-group><award-group><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100004875</institution-id><institution>Norrbacka-Eugeniastiftelsen</institution></institution-wrap></funding-source></award-group></funding-group><funding-group><award-group><funding-source><institution>Bertil and Ebon Norlins foundation</institution></funding-source></award-group></funding-group><funding-group><award-group><funding-source><institution>Lund University</institution></funding-source></award-group><open-access><p>Open access funding provided by Lund University.</p></open-access></funding-group><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>&#169; Springer-Verlag GmbH Germany, part of Springer Nature 2025</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="Sec1"><title>Introduction</title><p id="Par6">Postural instability is a cardinal sign of Parkinson&#8217;s disease (PD), and balance and gait difficulties are among the most distressing symptoms of PD [<xref ref-type="bibr" rid="CR3">3</xref>]. There is growing evidence that balance and gait difficulties as well as falls may occur early in the course of the disease, sometimes already in individuals with newly diagnosed, untreated PD (&#8220;de novo&#8221;) [<xref ref-type="bibr" rid="CR6">6</xref>, <xref ref-type="bibr" rid="CR12">12</xref>, <xref ref-type="bibr" rid="CR28">28</xref>, <xref ref-type="bibr" rid="CR29">29</xref>, <xref ref-type="bibr" rid="CR32">32</xref>, <xref ref-type="bibr" rid="CR34">34</xref>, <xref ref-type="bibr" rid="CR62">62</xref>, <xref ref-type="bibr" rid="CR63">63</xref>].</p><p id="Par7">Everyday transfers and activities (e.g., walking, turning, and transferring to/from sitting) induce self-generated perturbations that challenge balance. Walking is particularly challenging because the body is in a continuous state of imbalance, and the only way to prevent falling is to take the next step. PD-related walking difficulties are characterized by decreased gait speed, reduced step length, shuffling and turning difficulties, as well as freezing of gait (FOG). Walking may be affected by conducting motor and cognitive dual tasks [<xref ref-type="bibr" rid="CR31">31</xref>]. In addition, stooped posture, reduced arm swing [<xref ref-type="bibr" rid="CR31">31</xref>], and striatal foot deformities may aggravate balance and gait deficit [<xref ref-type="bibr" rid="CR36">36</xref>].</p><p id="Par8">It is also well-known that falls are one of the most disabling features of PD and become more common during the disease. History of falls is often suggested as the strongest significant predictor of future falls [<xref ref-type="bibr" rid="CR7">7</xref>, <xref ref-type="bibr" rid="CR31">31</xref>, <xref ref-type="bibr" rid="CR46">46</xref>]. However, this is of limited use when aiming to work proactively. Therefore, we have previously proposed to consider near falls that often precede actual falls. In fact, near falls have turned out to be the strongest predictor of future falls [<xref ref-type="bibr" rid="CR39">39</xref>]. Most falls occur while walking, but also while turning, transferring to/from sitting, bending forwards, or reaching [<xref ref-type="bibr" rid="CR31">31</xref>]. This highlights the importance of using assessments that mimic daily tasks and activities and target various aspects of balance and gait [<xref ref-type="bibr" rid="CR40">40</xref>, <xref ref-type="bibr" rid="CR44">44</xref>, <xref ref-type="bibr" rid="CR53">53</xref>, <xref ref-type="bibr" rid="CR61">61</xref>].</p><p id="Par9">Based on the presence of prominent motor symptoms investigated with the Unified Parkinson&#8217;s Disease Rating Scale (UPDRS) [<xref ref-type="bibr" rid="CR14">14</xref>] it is, by definition, stated that persons with the PD subtype Postural Instability and Gait Difficulty (PIGD) suffer from more severe balance and gait difficulties than the tremor dominant (TD) subtype [<xref ref-type="bibr" rid="CR26">26</xref>]. The key components of balance and gait evaluation according to UPDRS include assessment of reactive balance and ability to walk.</p><p id="Par10">In this study, we aimed to describe various aspects of balance and gait as well as falls and near falls in persons with de novo PD and to compare this with persons with mild-moderate PD. In addition, we evaluated differences relative to PD subtypes in persons with de novo PD.</p></sec><sec id="Sec2"><title>Methods</title><sec id="Sec3"><title>Participants and assessments</title><p id="Par11">All participants received care at a neurology outpatient clinic in southern Sweden and were consecutively recruited by a movement disorder specialist as a part of usual clinical care.</p><p id="Par12">Sixty-nine persons with suspected drug-naive PD were identified and considered for inclusion in the study during the years 2019&#8211;2021. Those who were unable to understand instructions (<italic toggle="yes">n</italic>&#8201;=&#8201;5) or had severe comorbidity (<italic toggle="yes">n</italic>&#8201;=&#8201;2) were excluded. Eight persons declined to participate. The final study sample included 54 persons, hereafter called de novo<italic toggle="yes"> PD</italic>. The diagnosis was made according to the Movement Disorders Society (MDS) diagnostic criteria [<xref ref-type="bibr" rid="CR54">54</xref>]. The decision to start anti-parkinsonian therapy involves consideration of individual symptoms and needs, and therefore could occur at different time-points after diagnosis.</p><p id="Par13">The de novo PD cohort was compared with an existing cohort collected during the years 2012&#8211;2017 for other purposes, using the same exclusion criteria [<xref ref-type="bibr" rid="CR38">38</xref>]. This cohort (<italic toggle="yes">n</italic>&#8201;=&#8201;58; hereafter called <italic toggle="yes">Later PD</italic>) consisted of people with a clinically established PD diagnosis according to United Kingdom Parkinson&#8217;s Disease Society Brain Bank criteria [<xref ref-type="bibr" rid="CR24">24</xref>]. The mean (SD) disease duration of Later PD cohort was 6.7 (3.7) years, and the median (<italic toggle="yes">q</italic>1&#8211;<italic toggle="yes">q</italic>3; min&#8211;max) daily levodopa equivalent (LDE) dose [<xref ref-type="bibr" rid="CR60">60</xref>] was 500 (400&#8211;675, 150&#8211;1580) mg/day. At the time of assessments, 48 out of the 58 participants (83%) self-rated their motor status as &#8220;good&#8221;, whereas 10 (17%) rated it as &#8220;bad&#8221;. More detailed descriptions of methods for recruitment of this cohort are available elsewhere [<xref ref-type="bibr" rid="CR37">37</xref>, <xref ref-type="bibr" rid="CR38">38</xref>].</p><p id="Par14">All assessments in both cohorts were conducted by the same specialist in neurological physiotherapy with extensive experience of PD (BL) during outpatient visits which were scheduled at a time of day when the participant usually reported feeling at his/her best. An overview of the assessments is presented in Table&#160;<xref rid="Tab1" ref-type="table">1</xref>. Assessments targeted motor symptoms [<xref ref-type="bibr" rid="CR14">14</xref>], activity of daily living [<xref ref-type="bibr" rid="CR14">14</xref>], disease severity staging [<xref ref-type="bibr" rid="CR21">21</xref>], cognition [<xref ref-type="bibr" rid="CR10">10</xref>, <xref ref-type="bibr" rid="CR13">13</xref>], as well as various aspects of balance and gait. The clinical test battery included evaluation of reactive balance (Nutt Retropulsion Test, NRT) [<xref ref-type="bibr" rid="CR61">61</xref>] and dynamic balance (tandem gait test, TG [<xref ref-type="bibr" rid="CR37">37</xref>, <xref ref-type="bibr" rid="CR45">45</xref>] mobility (timed up and go test, TUG) [<xref ref-type="bibr" rid="CR53">53</xref>] as well as comfortable and fast gait speed (10-Meter Walk Test, 10MWT [<xref ref-type="bibr" rid="CR40">40</xref>]). In addition, the participants completed questionnaires targeting balance problems while dual-tasking [<xref ref-type="bibr" rid="CR39">39</xref>], FOG [<xref ref-type="bibr" rid="CR50">50</xref>], and walking ability [<xref ref-type="bibr" rid="CR4">4</xref>]. As a last step of the outpatient visits, participants were asked to keep a diary for prospective recording of falls and near falls for 3&#160;months. Falls were defined as &#8220;an unexpected event in which the person comes to rest on the ground, floor, or lower level&#8221; [<xref ref-type="bibr" rid="CR39">39</xref>]. Near falls were defined as &#8220;a fall initiated but arrested by support from the wall, railing, other person, etc.&#8221; [<xref ref-type="bibr" rid="CR39">39</xref>].<table-wrap id="Tab1" position="float" orientation="portrait"><label>Table&#160;1</label><caption><p>Included assessments in both cohort</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" colspan="1" rowspan="1">Assessment</th><th align="left" colspan="1" rowspan="1">Score range</th><th align="left" colspan="1" rowspan="1">References</th></tr></thead><tbody><tr><td align="left" colspan="1" rowspan="1">Motor symptoms (UPDRS part III)</td><td align="left" colspan="1" rowspan="1">0&#8211;108<sup>a</sup></td><td align="left" colspan="1" rowspan="1">[<xref ref-type="bibr" rid="CR14">14</xref>]</td></tr><tr><td align="left" colspan="1" rowspan="1">Activities of daily living (UPDRS part II)<sup>b</sup></td><td align="left" colspan="1" rowspan="1">0&#8211;52<sup>a</sup></td><td align="left" colspan="1" rowspan="1">[<xref ref-type="bibr" rid="CR14">14</xref>]</td></tr><tr><td align="left" colspan="1" rowspan="1">Disease severity (H&amp;Y)</td><td align="left" colspan="1" rowspan="1">I&#8211;V<sup>a</sup></td><td align="left" colspan="1" rowspan="1">[<xref ref-type="bibr" rid="CR21">21</xref>]</td></tr><tr><td align="left" colspan="1" rowspan="1">Cognition (MOCA)</td><td align="left" colspan="1" rowspan="1">0&#8211;30<sup>c</sup></td><td align="left" colspan="1" rowspan="1">[<xref ref-type="bibr" rid="CR10">10</xref>]</td></tr><tr><td align="left" colspan="1" rowspan="1">Executive function (FAB)</td><td align="left" colspan="1" rowspan="1">0&#8211;18<sup>c</sup></td><td align="left" colspan="1" rowspan="1">[<xref ref-type="bibr" rid="CR13">13</xref>]</td></tr><tr><td align="left" colspan="1" rowspan="1"><p>Reactive balance (NRT)</p><p>Sudden, unexpected backward pull to the shoulders from behind when standing with feet slightly apart and eyes open</p></td><td align="left" colspan="1" rowspan="1"><p>0 (normal, may take 2 steps to recover)</p><p>1 (retropulsion, take 3 or more steps; recovers unaided)</p><p>2 (would fall if not caught)</p><p>3 (spontaneous tendency to fall or unable to stand unaided, test not executable)</p></td><td align="left" colspan="1" rowspan="1">[<xref ref-type="bibr" rid="CR61">61</xref>]</td></tr><tr><td align="left" colspan="1" rowspan="1"><p>Dynamic balance (TG)</p><p>Ten heel-to-toe steps along a straight line, with eyes open and without walking aids/support (those using walking aids were asked to try to perform TG without support)</p></td><td align="left" colspan="1" rowspan="1"><p>0 (no sidesteps)</p><p>1 (single sidestep)</p><p>2 (multiple sidesteps)</p><p>3 (unable to take 4 consecutive steps)</p></td><td align="left" colspan="1" rowspan="1">[<xref ref-type="bibr" rid="CR37">37</xref>, <xref ref-type="bibr" rid="CR44">44</xref>]</td></tr><tr><td align="left" colspan="1" rowspan="1"><p>Mobility (TUG)</p><p>Time (s) to rise from an armchair, walk at a comfortable and safe pace to a line on the floor three meters away, turn and walk back to the chair and sit down again</p></td><td align="left" colspan="1" rowspan="1">&#8201;&#8805;&#8201;0 s<sup>a</sup></td><td align="left" colspan="1" rowspan="1">[<xref ref-type="bibr" rid="CR53">53</xref>]</td></tr><tr><td align="left" colspan="1" rowspan="1"><p>Dual tasking difficulties</p><p>Do you experience balance problems while standing or walking when doing more than one thing at a time, e.g., carrying a tray while walking?</p></td><td align="left" colspan="1" rowspan="1">No/yes</td><td align="left" colspan="1" rowspan="1">[<xref ref-type="bibr" rid="CR39">39</xref>]</td></tr><tr><td align="left" colspan="1" rowspan="1"><p>Comfortable gait speed (CGS,10MWT)</p><p>Fast gait speed (FGS, 10MWT)</p></td><td align="left" colspan="1" rowspan="1">&#8201;&#8805;&#8201;0&#160;m/s<sup>c</sup></td><td align="left" colspan="1" rowspan="1">[<xref ref-type="bibr" rid="CR40">40</xref>]</td></tr><tr><td align="left" colspan="1" rowspan="1">Time (s) to walk 10&#160;m (without acceleration/deceleration distance) in comfortable and fast gait speed, respectively</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1"><p>Freezing of gait (FOG, item 3, FOGQsa)</p><p>Do you feel that your feet get glued to the floor while walking, making a turn or when trying to initiate walking?</p></td><td align="left" colspan="1" rowspan="1"><p>0 (never)</p><p>1 (very rarely&#8212;about once a month)</p><p>2 (rarely&#8212;about once a week)</p><p>3 (often&#8212;about once a day)</p><p>4 (always&#8212;whenever walking)</p></td><td align="left" colspan="1" rowspan="1">[<xref ref-type="bibr" rid="CR50">50</xref>]</td></tr><tr><td align="left" colspan="1" rowspan="1">Self-reported walking ability (Walk&#8211;12G)</td><td align="left" colspan="1" rowspan="1">0&#8211;42<sup>a</sup></td><td align="left" colspan="1" rowspan="1">[<xref ref-type="bibr" rid="CR4">4</xref>]</td></tr><tr><td align="left" colspan="1" rowspan="1"><p>Falls during three months follow-up</p><p>Did you fall in such a way that your body hit the ground?</p></td><td align="left" colspan="1" rowspan="1">No/yes</td><td align="left" colspan="1" rowspan="1">[<xref ref-type="bibr" rid="CR39">39</xref>]</td></tr><tr><td align="left" colspan="1" rowspan="1"><p>Near falls during three months follow-up</p><p>Were you close to falling, but managed to brace yourself at the last moment (e.g., grabbed on to someone, to an object or the wall?</p></td><td align="left" colspan="1" rowspan="1">No/yes</td><td align="left" colspan="1" rowspan="1">[<xref ref-type="bibr" rid="CR39">39</xref>]</td></tr></tbody></table><table-wrap-foot><p><italic toggle="yes">FOGQsa</italic> FOG Questionnaire, self&#8211;administered version; <italic toggle="yes">H&amp;Y</italic> Hoehn and Yahr stage, <italic toggle="yes">MOCA</italic> Montreal Cognitive Assessment, <italic toggle="yes">FAB</italic> frontal assessment battery, <italic toggle="yes">NRT</italic> Nutt Retropulsion Test, <italic toggle="yes">UPDRS</italic> Unified Parkinson&#8217;s Disease Rating Scale, <italic toggle="yes">10MWT</italic> 10-Meter Walk Test, <italic toggle="yes">m/s</italic> meters per second, <italic toggle="yes">TG</italic> Tandem Gait, <italic toggle="yes">TUG</italic> Timed Up and Go, <italic toggle="yes">Walk&#8211;12G</italic> 12&#8211;item generic walking scale</p><p><sup>a</sup>Higher&#8201;=&#8201;worse</p><p><sup>b</sup>Items 13&#8211;16 were used to estimate subtypes of PD[<xref ref-type="bibr" rid="CR16">16</xref>]</p><p><sup>c</sup>Higher&#8201;=&#8201;better</p></table-wrap-foot></table-wrap></p></sec><sec id="Sec4"><title>PD subtype classifications</title><p id="Par15">Participants were classified into the PIGD, tremor dominant (TD), and indeterminate (IT) subtypes of PD [<xref ref-type="bibr" rid="CR57">57</xref>]. The ratio of the mean UPDRS tremor scores (UPDRS III items 20&#8211;21 and UPDRS II item 16) to the mean UPDRS PIGD scores (UPDRS III items 29 and 30 and UPDRS II items 13&#8211;15) was used to identify PIGD subtype (ratio&#8201;&#8804;&#8201;1), TD subtype (ratio&#8201;&#8805;&#8201;1.5) and IT subtype (ratios&#8201;&gt;&#8201;1.0 and&#8201;&lt;&#8201;1.5).</p></sec><sec id="Sec5"><title>Statistical analysis</title><p id="Par16">IBM SPSS software version 25.0 was used to perform all statistical analyses. Normally distributed interval/ratio level variables were described using means and SDs. In other cases, medians (<italic toggle="yes">q</italic>1&#8211;<italic toggle="yes">q</italic>3) were used. Categorical variables were described using n (%). For between-group comparisons, the independent samples <italic toggle="yes">t</italic> test or Mann&#8211;Whitney <italic toggle="yes">U</italic> test was used as appropriate, and the Chi-square test was used for categorical variables. The alpha level of significance was set at 0.05 (two tailed).</p></sec></sec><sec id="Sec6"><title>Results</title><sec id="Sec7"><title>De novo PD cohort</title><p id="Par17">The mean (SD) age of the de novo PD cohort (<italic toggle="yes">n</italic>&#8201;=&#8201;54) was 67 (11.0) years and included 20 (37%) females. The median (<italic toggle="yes">q</italic>1&#8211;<italic toggle="yes">q</italic>3, min&#8211;max) UPDRS III score was 21 (14&#8211;28; 8&#8211;53). At least one-fourth of the de novo PD had abnormal reactive balance and needed three or more steps or support to prevent falling during unexpected shoulder pull (NRT). At least half had abnormal dynamic balance and needed to take at least one single sidestep during TG. At least one-fourth of these presented multiple sidesteps or inability to take four consecutive heel-to-toe steps. Fifteen participants (29%) reported balance problems while standing or walking when doing more than one thing at a time, e.g., carrying a tray while walking. At least one-fourth had a comfortable gait speed of&#8201;&#8804;&#8201;1.0&#160;m/s. Five participants (9%) reported experience of falls/near falls during the 3-month follow-up. Further details are presented in Table&#160;<xref rid="Tab2" ref-type="table">2</xref>.<table-wrap id="Tab2" position="float" orientation="portrait"><label>Table&#160;2</label><caption><p>Characteristics and comparison of de novo PD vs Later PD</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" colspan="1" rowspan="1"/><th align="left" colspan="1" rowspan="1">De novo PD<break/><italic toggle="yes">N</italic>&#8201;=&#8201;54</th><th align="left" colspan="1" rowspan="1">Later PD<break/><italic toggle="yes">N</italic>&#8201;=&#8201;58</th><th align="left" colspan="1" rowspan="1"><italic toggle="yes">p</italic> value</th></tr></thead><tbody><tr><td align="left" colspan="1" rowspan="1">Age (years)</td><td align="left" colspan="1" rowspan="1">67 (11.0; 42&#8211;83)</td><td align="left" colspan="1" rowspan="1">69 (8.9, 46&#8211;84)</td><td char="." align="char" colspan="1" rowspan="1">0.216<sup>d</sup></td></tr><tr><td align="left" colspan="1" rowspan="1">Female gender</td><td align="left" colspan="1" rowspan="1">20 (37)</td><td align="left" colspan="1" rowspan="1">32 (55)</td><td char="." align="char" colspan="1" rowspan="1">0.560<sup>c</sup></td></tr><tr><td align="left" colspan="1" rowspan="1">Disease severity (HY)<sup>a</sup></td><td align="left" colspan="1" rowspan="1">II (II&#8211;II; I&#8211;IV)</td><td align="left" colspan="1" rowspan="1">II (II&#8211;III; I&#8211;IV)</td><td char="." align="char" colspan="1" rowspan="1">0.114<sup>e</sup></td></tr><tr><td align="left" colspan="1" rowspan="1">Cognition (MOCA)<sup>b</sup></td><td align="left" colspan="1" rowspan="1">26 (24&#8211;27; 20&#8211;30)</td><td align="left" colspan="1" rowspan="1">25 (23&#8211;27;14&#8211;30)</td><td char="." align="char" colspan="1" rowspan="1">0.329<sup>e</sup></td></tr><tr><td align="left" colspan="1" rowspan="1">Executive function (FAB)<sup>b</sup></td><td align="left" colspan="1" rowspan="1">16 (14&#8211;16; 3&#8211;18)</td><td align="left" colspan="1" rowspan="1">16 (14&#8211;17; 7&#8211;18)</td><td char="." align="char" colspan="1" rowspan="1">0.766<sup>e</sup></td></tr><tr><td align="left" colspan="1" rowspan="1">Motor symptoms (UPDRS)<sup>a</sup></td><td align="left" colspan="1" rowspan="1">21 (14&#8211;28; 8&#8211;53)</td><td align="left" colspan="1" rowspan="1">13.5 (9&#8211;20; 1&#8211;40)</td><td char="." align="char" colspan="1" rowspan="1"><bold>&#8201;&lt;&#8201;0.001</bold><sup><bold>e</bold></sup></td></tr><tr><td align="left" colspan="1" rowspan="1">Reactive balance (NRT)<sup>a</sup></td><td align="left" colspan="1" rowspan="1">0 (0&#8211;1; 0&#8211;2)</td><td align="left" colspan="1" rowspan="1">0 (0&#8211;1; 0&#8211;3)</td><td char="." align="char" colspan="1" rowspan="1">0.432<sup>e</sup></td></tr><tr><td align="left" colspan="1" rowspan="1">Dynamic balance (TG)<sup>a</sup></td><td align="left" colspan="1" rowspan="1">1 (0&#8211;2; 0&#8211;3)</td><td align="left" colspan="1" rowspan="1">2 (0&#8211;3;0&#8211;3)</td><td char="." align="char" colspan="1" rowspan="1"><bold>0.048</bold><sup><bold>e</bold></sup></td></tr><tr><td align="left" colspan="1" rowspan="1">Mobility (TUG), s<sup>a</sup></td><td align="left" colspan="1" rowspan="1">9.2 (7.7&#8211;10.7; 6.4&#8211;28.4)</td><td align="left" colspan="1" rowspan="1">10.5 (8.5&#8211;13.1; 6.8&#8211;54.1)</td><td char="." align="char" colspan="1" rowspan="1"><bold>0.013</bold><sup><bold>e</bold></sup></td></tr><tr><td align="left" colspan="1" rowspan="1">Dual tasking difficulties</td><td align="left" colspan="1" rowspan="1">15 (29)<sup>n=51</sup></td><td align="left" colspan="1" rowspan="1">29 (52)<sup>n=56</sup></td><td char="." align="char" colspan="1" rowspan="1"><bold>0.019</bold><sup><bold>c</bold></sup></td></tr><tr><td align="left" colspan="1" rowspan="1">CGS (10MWT), m/s<sup>b</sup></td><td align="left" colspan="1" rowspan="1">1.1 (1.0&#8211;1.3; 0.5&#8211;1.6)</td><td align="left" colspan="1" rowspan="1">1.2 (0.9&#8211;1.3; 0.4&#8211;1.7)</td><td char="." align="char" colspan="1" rowspan="1">0.786<sup>e</sup></td></tr><tr><td align="left" colspan="1" rowspan="1">FGS (10MWT), m/s<sup>b</sup></td><td align="left" colspan="1" rowspan="1">1.6 (1.3&#8211;1.9; 0.6&#8211;1.3)</td><td align="left" colspan="1" rowspan="1">1.5 (1.2&#8211;1.8; 0.5&#8211;2.3)</td><td char="." align="char" colspan="1" rowspan="1">0.086<sup>e</sup></td></tr><tr><td align="left" colspan="1" rowspan="1">FOG (FOGQsa item 3)<sup>a</sup></td><td align="left" colspan="1" rowspan="1">0 (0&#8211;0; 0&#8211;4)<sup>n=47</sup></td><td align="left" colspan="1" rowspan="1">1 (0&#8211;3; 0&#8211;4)</td><td char="." align="char" colspan="1" rowspan="1"><bold>&#8201;&lt;&#8201;0.001</bold><sup><bold>e</bold></sup></td></tr><tr><td align="left" colspan="1" rowspan="1">Walking ability (Walk12G)<sup>a</sup></td><td align="left" colspan="1" rowspan="1">7 (1&#8211;16; 0&#8211;33)<sup>n=48</sup></td><td align="left" colspan="1" rowspan="1">10 (5&#8211;24; 0&#8211;42)<sup>n=56</sup></td><td char="." align="char" colspan="1" rowspan="1"><bold>0.006</bold><sup><bold>e</bold></sup></td></tr><tr><td align="left" colspan="1" rowspan="1">Number of individuals with one or more prospective falls</td><td align="left" colspan="1" rowspan="1">5 (9)</td><td align="left" colspan="1" rowspan="1">26 (45)</td><td char="." align="char" colspan="1" rowspan="1"><bold>&#8201;&lt;&#8201;0.001</bold><sup><bold>c</bold></sup></td></tr><tr><td align="left" colspan="1" rowspan="1">Number of Individuals with one or more prospective near falls</td><td align="left" colspan="1" rowspan="1">5 (9)</td><td align="left" colspan="1" rowspan="1">19 (33)</td><td char="." align="char" colspan="1" rowspan="1"><bold>&#8201;&lt;&#8201;0.001</bold><sup><bold>c</bold></sup></td></tr></tbody></table><table-wrap-foot><p>Values are mean (SD; min&#8211;max), median (<italic toggle="yes">q</italic>1&#8211;<italic toggle="yes">q</italic>3; min&#8211;max) or n (%). Significant <italic toggle="yes">p</italic> values are indicated in bold</p><p><italic toggle="yes">CGS</italic> comfortable gait speed, <italic toggle="yes">FAB</italic> frontal assessment battery, <italic toggle="yes">FGS</italic> Fast Gait speed, <italic toggle="yes">FOGQsa</italic> Freezing of Gait Questionnaire self-administered version, <italic toggle="yes">H&amp;Y</italic> Hoehn and Yahr stage, <italic toggle="yes">MOCA</italic> Montreal Cognitive Assessment<italic toggle="yes">,</italic>
<italic toggle="yes">NRT</italic> Nutt Retropulsion Test, <italic toggle="yes">UPDRS</italic> Unified Parkinson&#8217;s Disease Rating Scale, <italic toggle="yes">10MWT</italic> 10-Meter Walk Test, <italic toggle="yes">m/s</italic> meters per second, <italic toggle="yes">TG</italic> Tandem Gait, <italic toggle="yes">TUG</italic> Timed Up and Go, <italic toggle="yes">Walk&#8211;12G</italic> 12-item generic walking scale</p><p><sup>a</sup>Higher&#8201;=&#8201;worse</p><p><sup>b</sup>Higher&#8201;=&#8201;better</p><p><sup>c</sup>Chi-test</p><p><sup>d</sup>Student&#8217;s <italic toggle="yes">T</italic> test</p><p><sup>e</sup>Mann&#8211;Whitney <italic toggle="yes">U</italic> test</p></table-wrap-foot></table-wrap></p></sec><sec id="Sec8"><title>De novo PD cohort vs Later PD cohort</title><p id="Par18">Comparison between participants with de novo PD (<italic toggle="yes">n</italic>&#8201;=&#8201;54) and Later PD (<italic toggle="yes">n</italic>&#8201;=&#8201;58) did not show any differences regarding age or gender (Table&#160;<xref rid="Tab2" ref-type="table">2</xref>). Clinical assessments showed that participants with de novo PD had more motor symptoms but performed better on dynamic balance (TG) and mobility (TUG) tests than those with Later PD. De novo PD also had better self-reported walking ability, less FOG, and dual-tasking difficulties, and a lower percentage of individuals with falls/near falls. There were no differences between de novo and Later PD regarding reactive balance and comfortable or fast gait speed. Further details are presented in Table&#160;<xref rid="Tab2" ref-type="table">2</xref>.</p></sec><sec id="Sec9"><title>De novo PIGD PD cohort vs de novo non-PIGD cohort</title><p id="Par19">The PD subtype could not be determined for 7 of 54 participants due to missing data. Ten of the remaining forty-seven participants were identified as PIGD, thirty-six as TD, and one participant as IT subtype. Due to relatively small samples, the IT and TD subtypes were combined to form a single non&#8211;PIGD (<italic toggle="yes">n</italic>&#8201;=&#8201;37) [<xref ref-type="bibr" rid="CR52">52</xref>].</p><p id="Par20">There were no differences between subtypes regarding age or gender (Table&#160;<xref rid="Tab3" ref-type="table">3</xref>). However, those with the PIGD subtype exhibited worse motor symptoms, reactive and dynamic balance, mobility, comfortable and fast gait speed, FOG, and self-reported walking ability, as compared to those with the non-PIGD subtype (<italic toggle="yes">p</italic>&#8201;&#8804;&#8201;0.049). There were no differences between subtypes regarding dual-tasking difficulties and falls/near falls.<table-wrap id="Tab3" position="float" orientation="portrait"><label>Table&#160;3</label><caption><p>Comparison of de novo PD with postural instability and gait (PIGD) subtype vs de novo PD with non-PIGD subtype</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" colspan="1" rowspan="1"/><th align="left" colspan="1" rowspan="1">De novo PIGD PD<break/><italic toggle="yes">N</italic>&#8201;=&#8201;10</th><th align="left" colspan="1" rowspan="1">De novo non-PIGD PD<break/><italic toggle="yes">N</italic>&#8201;=&#8201;37</th><th align="left" colspan="1" rowspan="1"><italic toggle="yes">p</italic> value</th></tr></thead><tbody><tr><td align="left" colspan="1" rowspan="1">Age (years)</td><td align="left" colspan="1" rowspan="1">69 (5.0; 64&#8211;78)</td><td align="left" colspan="1" rowspan="1">66 (11.7; 45&#8211;83)<sup>d</sup></td><td char="." align="char" colspan="1" rowspan="1">0.582<sup>d</sup></td></tr><tr><td align="left" colspan="1" rowspan="1">Female gender</td><td align="left" colspan="1" rowspan="1">4 (40)</td><td align="left" colspan="1" rowspan="1">14 (38)</td><td char="." align="char" colspan="1" rowspan="1">0.999<sup>c</sup></td></tr><tr><td align="left" colspan="1" rowspan="1">Disease severity (HY)<sup>a</sup></td><td align="left" colspan="1" rowspan="1">III (II&#8211;III; II&#8211;III)</td><td align="left" colspan="1" rowspan="1">II (II&#8211;II; I&#8211;III)</td><td char="." align="char" colspan="1" rowspan="1"><bold>0.001</bold><sup><bold>e</bold></sup></td></tr><tr><td align="left" colspan="1" rowspan="1">Cognition (MOCA)<sup>b</sup></td><td align="left" colspan="1" rowspan="1">24.5 (23&#8211;27; 21&#8211;29)</td><td align="left" colspan="1" rowspan="1">26 (24&#8211;28; 17&#8211;30)</td><td char="." align="char" colspan="1" rowspan="1">0.487<sup>e</sup></td></tr><tr><td align="left" colspan="1" rowspan="1">Executive function (FAB)<sup>b</sup></td><td align="left" colspan="1" rowspan="1">14.5 (11&#8211;17; 9&#8211;17)</td><td align="left" colspan="1" rowspan="1">16 (15&#8211;17; 3&#8211;18)</td><td char="." align="char" colspan="1" rowspan="1">0.241<sup>e</sup></td></tr><tr><td align="left" colspan="1" rowspan="1">Motor symptoms (UPDRS)<sup>a</sup></td><td align="left" colspan="1" rowspan="1">26 (21&#8211;34; 13&#8211;42)</td><td align="left" colspan="1" rowspan="1">18 (14&#8211;25; 8&#8211;53)</td><td char="." align="char" colspan="1" rowspan="1"><bold>0.049</bold><sup><bold>e</bold></sup></td></tr><tr><td align="left" colspan="1" rowspan="1">Reactive balance (NRT)<sup>a</sup></td><td align="left" colspan="1" rowspan="1">2 (0&#8211;2; 0&#8211;2)</td><td align="left" colspan="1" rowspan="1">0 (0&#8211;0; 0&#8211;2)</td><td char="." align="char" colspan="1" rowspan="1"><bold>&#8201;&lt;&#8201;0.001</bold><sup><bold>e</bold></sup></td></tr><tr><td align="left" colspan="1" rowspan="1">Dynamic balance (TG)<sup>a</sup></td><td align="left" colspan="1" rowspan="1">3 (1&#8211;3; 0&#8211;3)</td><td align="left" colspan="1" rowspan="1">0 (0&#8211;1; 0&#8211;3)</td><td char="." align="char" colspan="1" rowspan="1"><bold>0.003</bold><sup><bold>e</bold></sup></td></tr><tr><td align="left" colspan="1" rowspan="1">Mobility (TUG), s<sup>a</sup></td><td align="left" colspan="1" rowspan="1">10.8 (10.3&#8211;12.0; 7.3&#8211;15.0)</td><td align="left" colspan="1" rowspan="1">8.9 (7.6&#8211;10.5; 6.4&#8211;19.1)</td><td char="." align="char" colspan="1" rowspan="1"><bold>0.013</bold><sup><bold>e</bold></sup></td></tr><tr><td align="left" colspan="1" rowspan="1">Dual tasking difficulties</td><td align="left" colspan="1" rowspan="1">4 (44) <sup>n=9</sup></td><td align="left" colspan="1" rowspan="1">9 (26) <sup>n=35</sup></td><td char="." align="char" colspan="1" rowspan="1">0.272<sup>c</sup></td></tr><tr><td align="left" colspan="1" rowspan="1">CGS (10MWT), m/s<sup>b</sup></td><td align="left" colspan="1" rowspan="1">1.0 (0.9&#8211;1.0; 0.6&#8211;1.1)</td><td align="left" colspan="1" rowspan="1">1.2 (0.9&#8211;1.4; 0.5&#8211;1.6)</td><td char="." align="char" colspan="1" rowspan="1"><bold>0.009</bold><sup><bold>e</bold></sup></td></tr><tr><td align="left" colspan="1" rowspan="1">FGS (10MWT), m/s<sup>b</sup></td><td align="left" colspan="1" rowspan="1">1.3 (1.3&#8211;1.6; 0.8&#8211;1.7)</td><td align="left" colspan="1" rowspan="1">1.7 (1.4&#8211;2.1; 0.7&#8211;3.1)</td><td char="." align="char" colspan="1" rowspan="1"><bold>0.020</bold><sup><bold>e</bold></sup></td></tr><tr><td align="left" colspan="1" rowspan="1">FOG (FOGQsa item 3)<sup>a</sup></td><td align="left" colspan="1" rowspan="1">0 (0&#8211;4; 0&#8211;4)</td><td align="left" colspan="1" rowspan="1">0 (0&#8211;0; 0&#8211;2)</td><td char="." align="char" colspan="1" rowspan="1"><bold>0.002</bold><sup><bold>e</bold></sup></td></tr><tr><td align="left" colspan="1" rowspan="1">Walking ability (Walk12G)<sup>a</sup></td><td align="left" colspan="1" rowspan="1">17.5 (13&#8211;20; 8&#8211;30)</td><td align="left" colspan="1" rowspan="1">4 (1&#8211;12; 0&#8211;33)</td><td char="." align="char" colspan="1" rowspan="1"><bold>&#8201;&lt;&#8201;0.001</bold><sup><bold>e</bold></sup></td></tr><tr><td align="left" colspan="1" rowspan="1">Number of individuals with one or more prospective falls</td><td align="left" colspan="1" rowspan="1">2 (20)</td><td align="left" colspan="1" rowspan="1">2 (5)</td><td char="." align="char" colspan="1" rowspan="1">0.142<sup>c</sup></td></tr><tr><td align="left" colspan="1" rowspan="1">Number of individuals with one or more prospective near falls</td><td align="left" colspan="1" rowspan="1">1 (10)</td><td align="left" colspan="1" rowspan="1">3 (8)</td><td char="." align="char" colspan="1" rowspan="1">0.849<sup>c</sup></td></tr></tbody></table><table-wrap-foot><p>Values are mean (SD; min&#8211;max), median (q1&#8211;q3; min&#8211;max) or n (%). Significant p-values are indicated in bold</p><p><italic toggle="yes">CGS</italic> comfortable gait speed, <italic toggle="yes">FAB</italic> frontal assessment battery, <italic toggle="yes">FGS</italic> Fast Gait speed, <italic toggle="yes">FOGQsa</italic> Freezing of Gait Questionnaire self-administered version, <italic toggle="yes">H&amp;Y</italic> Hoehn and Yahr stage, <italic toggle="yes">MOCA</italic> Montreal Cognitive Assessment<italic toggle="yes">,</italic>
<italic toggle="yes">NRT</italic> Nutt Retropulsion Test, <italic toggle="yes">UPDRS</italic> Unified Parkinson&#8217;s Disease Rating Scale, <italic toggle="yes">10MWT</italic> 10-Meter Walk Test, <italic toggle="yes">m/s</italic> meters per second, <italic toggle="yes">TG</italic> Tandem Gait, <italic toggle="yes">TUG</italic> Timed Up and Go, <italic toggle="yes">Walk&#8211;12G</italic> 12-item generic walking scale</p><p><sup>a</sup>Higher&#8201;=&#8201;worse</p><p><sup>b</sup>Higher&#8201;=&#8201;better</p><p><sup>c</sup>Chi&#8211;test</p><p><sup>d</sup>Student's <italic toggle="yes">T</italic> test</p><p><sup>e</sup>Mann&#8211;Whitney <italic toggle="yes">U</italic> test</p></table-wrap-foot></table-wrap></p></sec></sec><sec id="Sec10"><title>Discussion</title><p id="Par21">We found that various aspects of balance and gait are impaired already in newly diagnosed PD and, as expected, more pronounced among participants with the PIGD subtype. Falls/near falls also occurred early but were not subtype-specific. Although the group with de novo PD showed more motor symptoms than the later-stage cohort, they had better balance and gait ability and less falls/near falls.</p><p id="Par22">Our findings are in line with previous studies highlighting early deficits of balance and gait in PD [<xref ref-type="bibr" rid="CR6">6</xref>, <xref ref-type="bibr" rid="CR12">12</xref>, <xref ref-type="bibr" rid="CR28">28</xref>, <xref ref-type="bibr" rid="CR29">29</xref>, <xref ref-type="bibr" rid="CR32">32</xref>, <xref ref-type="bibr" rid="CR34">34</xref>, <xref ref-type="bibr" rid="CR62">62</xref>, <xref ref-type="bibr" rid="CR63">63</xref>]. For example, longitudinal results suggest that balance impairments exist even at the drug-naive early stages of the disease and worsen during the ensuing 5&#160;years [<xref ref-type="bibr" rid="CR28">28</xref>]. Despite this growing evidence, recent reviews [<xref ref-type="bibr" rid="CR2">2</xref>, <xref ref-type="bibr" rid="CR59">59</xref>] still describe postural instability and falls as occurring in the more advanced stages of the disease. This may contribute to a delay in participation in neurorehabilitation programs which can lead to increased suffering, accidents, and unnecessary community costs [<xref ref-type="bibr" rid="CR17">17</xref>]. Meanwhile, and as suggested previously, our findings imply that successful symptomatic medication in the more advanced stages of PD has less effects on demanding aspects of balance and gait [<xref ref-type="bibr" rid="CR5">5</xref>, <xref ref-type="bibr" rid="CR16">16</xref>, <xref ref-type="bibr" rid="CR23">23</xref>, <xref ref-type="bibr" rid="CR28">28</xref>, <xref ref-type="bibr" rid="CR42">42</xref>, <xref ref-type="bibr" rid="CR43">43</xref>, <xref ref-type="bibr" rid="CR46">46</xref>, <xref ref-type="bibr" rid="CR49">49</xref>]. This indicates a need for alternative treatment efforts and screening for fall risk already from an early stage of the disease. In fact, early referral to physiotherapy for examination, advice, and interventions has been recently recommended [<xref ref-type="bibr" rid="CR16">16</xref>].</p><p id="Par23">A comfortable gait speed of&#8201;&lt;&#8201;1.1&#160;m/s is a well-known independent predictor of future falls in people with PD [<xref ref-type="bibr" rid="CR31">31</xref>]. At least one-fourth of our de novo PD cohort presented gait speeds below this cutoff value. Similar results for persons with de novo PD have been reported earlier [<xref ref-type="bibr" rid="CR32">32</xref>, <xref ref-type="bibr" rid="CR34">34</xref>]. The reduced gait speed might be due to brady/hypokinesia and can be improved by anti-parkinsonian medication [<xref ref-type="bibr" rid="CR11">11</xref>, <xref ref-type="bibr" rid="CR32">32</xref>]. However, the causal relation between gait speed, motor subtypes, training, and medication should be best studied in a longitudinal study design that preferably commences at the time of diagnosis. However, such studies are resource-demanding and rare.</p><p id="Par24">Our results regarding the occurrence of early deficit in reactive balance are largely in line with previously reported findings [<xref ref-type="bibr" rid="CR28">28</xref>], Reactive balance according to NRT reflects everyday life situations when the balance is often challenged by unexpected self-perturbation due to, e.g., tripping [<xref ref-type="bibr" rid="CR61">61</xref>]. Abnormal NRT performance has been suggested as a better predictor of falls in PD than item 30 of the UPDRS which involves an expected shoulder pull [<xref ref-type="bibr" rid="CR61">61</xref>]. Thus, at least one-fourth of the de novo PD cohort has an increased risk of falling due to everyday self-perturbation. Moreover, a comparison between the de novo PD and Later stages PD did not show differences in NRT scores. This finding is in line with previous studies reporting that postural instability responds poorly to dopaminergic therapy [<xref ref-type="bibr" rid="CR15">15</xref>, <xref ref-type="bibr" rid="CR49">49</xref>].</p><p id="Par25">This study appears to be the first to report on dynamic balance in de novo PD. However, the importance of TG for the investigation of dynamic balance in the later stages of PD has been highlighted before [<xref ref-type="bibr" rid="CR37">37</xref>, <xref ref-type="bibr" rid="CR44">44</xref>, <xref ref-type="bibr" rid="CR45">45</xref>]. Abnormal test performance was observed in at least half of our de novo PD cohort. The critical point of tandem gait is the exact foot placement and ability to keep the center of mass within a very narrow base of support [<xref ref-type="bibr" rid="CR58">58</xref>]. This test challenges mediolateral stability&#8212;an important aspect of postural stability in PD that, if impaired, may contribute to falls [<xref ref-type="bibr" rid="CR22">22</xref>, <xref ref-type="bibr" rid="CR30">30</xref>, <xref ref-type="bibr" rid="CR37">37</xref>].</p><p id="Par26">Early identification of FOG in PD is of particular importance because of its high association with falls [<xref ref-type="bibr" rid="CR31">31</xref>]. FOG was reported by some individuals in our de novo cohort. This result is in line with a recently published study that also reported early occurrence of FOG in drug-naive PD [<xref ref-type="bibr" rid="CR56">56</xref>]. Importantly, according to recent reviews, the frequency of FOG increases as PD progresses and is usually seen in the later stages of the disease [<xref ref-type="bibr" rid="CR2">2</xref>, <xref ref-type="bibr" rid="CR59">59</xref>]. Thus, it is plausible that some of the de novo PD were later in the course of disease than expected at the time of diagnosis. In fact, some individuals in our de novo PD cohort demonstrated impaired cognition which is also attributed to later stages of the disease [<xref ref-type="bibr" rid="CR2">2</xref>, <xref ref-type="bibr" rid="CR59">59</xref>]. Limited access to neurologists and/or delayed referral from health care may be potential explanations. In both cases, the administration of anti-parkinsonian medication and referral to a beyond becomes unnecessarily delayed, which can have negative consequences on activities of everyday life and quality of life. In fact, according to the Swedish National Parkinson's Disease Patient Registry (PARKreg), the time between onset of Parkinsonian symptoms and diagnosis was as long as 1&#8211;2&#160;years [<xref ref-type="bibr" rid="CR19">19</xref>]. However, in some cases, a person could be de novo because of medical or own decision to not start medication. That may contribute to a variety of balance and gait impairments in our de novo PD cohort. Finally, PD diagnosis may be uncertain in the early stages of the disease and misdiagnoses may occur in up to 24% [<xref ref-type="bibr" rid="CR59">59</xref>]. That speaks again for the importance of early care at the specialist clinic.</p><p id="Par27">Motor symptoms in de novo PD were generally milder than those observed in previous studies [<xref ref-type="bibr" rid="CR27">27</xref>, <xref ref-type="bibr" rid="CR33">33</xref>, <xref ref-type="bibr" rid="CR34">34</xref>]. For example, the median UPDRS III score for drug-naive early stages of PD, presented by Johansson et al. [<xref ref-type="bibr" rid="CR28">28</xref>], was 26, as compared to 21 in our cohort, whereas our cohort was younger than that of Johansson et al. (mean age 67 vs. 71&#160;years). However, this is in line with previous observations suggesting a more rapid progression among older than younger persons with PD [<xref ref-type="bibr" rid="CR1">1</xref>, <xref ref-type="bibr" rid="CR18">18</xref>, <xref ref-type="bibr" rid="CR20">20</xref>].</p><p id="Par28">We also found that the treated Later PD cohort with less motor score/symptoms than the de novo PD cohort had worse dynamic balance (TG) and mobility (TUG). TG and TUG focus on more advanced balance in everyday activities such as walking with a narrow base of support, transferring to/from sitting, and turning that are often affected by PD, especially when performed as a sequence [<xref ref-type="bibr" rid="CR31">31</xref>]. Later PD also presented a higher percentage of individuals with dual-tasking difficulties, and a much higher percentage of those who reported falls/near falls. Also, self-reported walking ability was significantly worse in Later PD in comparison to de novo PD. Altogether, our results support the need of early rehabilitation in addition to dopaminergic medication [<xref ref-type="bibr" rid="CR16">16</xref>, <xref ref-type="bibr" rid="CR46">46</xref>]. Importantly there is also evidence showing that side effects of medication such as dyskinesia has a negative impact on balance and falls in people with PD [<xref ref-type="bibr" rid="CR9">9</xref>, <xref ref-type="bibr" rid="CR35">35</xref>]. In line with this recently established world guidelines for falls prevention and management for older adults highlighted optimization of medications as a critical step to falls prevention in PD treatment [<xref ref-type="bibr" rid="CR46">46</xref>].</p><sec id="Sec11"><title>Clinical implications</title><p id="Par29">The results from testing of various aspects of balance and gait showed that about 25&#8211;50% of de novo PD presented values beyond the suggested cutoff scores for increased risk of falling in PD [<xref ref-type="bibr" rid="CR31">31</xref>, <xref ref-type="bibr" rid="CR37">37</xref>]. That implies that early monitoring of balance and gait may be helpful in identifying individuals with early impairments and give the possibility to adapt neurorehabilitation programs based on individual symptom profiles. For example, treadmill training, strategy training (including cueing), balance and gait training, martial arts (Tai Chi and Qigong), and exergaming have been shown to increase gait speed [<xref ref-type="bibr" rid="CR55">55</xref>]. In patients with mediolateral imbalance, physiotherapists may teach PD patients to widen their step width during gait [<xref ref-type="bibr" rid="CR22">22</xref>, <xref ref-type="bibr" rid="CR30">30</xref>]. In FOG, specific cuing strategies that improve balance and gait may be applied as an alternative treatment to dopaminergic treatment [<xref ref-type="bibr" rid="CR2">2</xref>, <xref ref-type="bibr" rid="CR55">55</xref>]. Exercising also has shown positive effects on reactive balance in PD [<xref ref-type="bibr" rid="CR49">49</xref>]. The impact of such training on the reduction of falls in PD is also promising [<xref ref-type="bibr" rid="CR25">25</xref>]. Importantly, key PD trials in rehabilitation and fall prevention showed different results across progression of the disease that may be related to the level of supervision, intensity, or dose of the interventions [<xref ref-type="bibr" rid="CR8">8</xref>, <xref ref-type="bibr" rid="CR47">47</xref>, <xref ref-type="bibr" rid="CR48">48</xref>]. For example, less-supervised home-based exercise programs reduce falls in mild PD but not in more sever disease stage [<xref ref-type="bibr" rid="CR8">8</xref>]. That speaks again for the importance of early and regular monitoring of PD progression preferably provided by a multidisciplinary specialist team.</p></sec><sec id="Sec12"><title>Limitations and strengths</title><p id="Par30">Our cohorts were small, and the power of the analyses is, therefore, compromised especially for comparisons between PIGD and non-PIGD subtypes. It might also be of value to have been able to compare the de novo group to a healthy control group to distinguish age differences. In this study, we utilized commonly used clinical tests of balance and gait and found impairments in the de novo group. Interestingly more sensitive &#8220;laboratory&#8221; methods such as motion analysis with inertial sensors or pressure-sensitive mats have shown similar impairments in balance and gait [<xref ref-type="bibr" rid="CR12">12</xref>, <xref ref-type="bibr" rid="CR29">29</xref>, <xref ref-type="bibr" rid="CR32">32</xref>] indicating that these differences can be revealed with clinical assessments but probably more detected with more sensitive methods.</p><p id="Par31">The strength of our study is, however, that both cohorts were consecutively recruited at the same clinic and assessed by the same physiotherapist (BL). However, the recruitment of cohorts did not take place at the same time, but in both cases, the study procedure followed the clinical routines; de novo PD started medication at individual time-points during the 3-month follow-up, and medication adjustment was done when needed in Later PD.</p><p id="Par32">The test battery was selected to cover various aspects of balance and gait and included assessments that are easy and quick to implement in clinical settings. However, the outcome from some of these tests, such as NRT or TG, can vary considerably due to variability in test execution [<xref ref-type="bibr" rid="CR45">45</xref>, <xref ref-type="bibr" rid="CR51">51</xref>]. Therefore, in future studies, it should be of value to use a uniform valid, and reliable assessment that covers various aspects of balance and gait, e.g., Mini-BESTest [<xref ref-type="bibr" rid="CR41">41</xref>].</p></sec></sec><sec id="Sec13"><title>Conclusion</title><p id="Par33">Balance and gait were impaired in de novo PD and most pronounced in PIGD subtype. In addition, dual-task difficulties and falls/near falls were evident during this early stage. The lower scores of motor symptoms in Later PD did not result in better mobility, balance, or less falls/near falls indicating that medications have less effect on these symptoms.</p></sec></body><back><ack><title>Acknowledgements</title><p>The authors are grateful to all participants for their contribution to this study. This work was supported by Stoltz foundation, Sk&#229;ne County Council&#8217;s research and development foundation, The Erik Hardebos foundation, Kockska foundation, Neuro foundation, Norrbacka-Eugenia foundation and Bertil and Ebon Norlins foundation. The authors declare no conflicts of interest relevant to this work.</p></ack><notes notes-type="funding-information"><title>Funding</title><p>Open access funding provided by Lund University. Stoltz foundation, Sk&#229;ne County Council's Research and Development Foundation, The Erik Hardebos foundation, Kockska foundation, Neuro foundation, Norrbacka-Eugeniastiftelsen, Bertil and Ebon Norlins foundation.</p></notes><notes notes-type="data-availability"><title>Data availability</title><p>The data supporting the findings of this study are available on request from the corresponding author. The data are not publicly available due to privacy or ethical restrictions.</p></notes><notes><title>Declarations</title><notes id="FPar1" notes-type="COI-statement"><title>Conflicts of interest</title><p id="Par34">The authors have no conflict of interest to report.</p></notes><notes id="FPar2"><title>Ethics statement</title><p id="Par35">The Regional Ethical Review Board in Lund approved the study (Dnr 2011/768 and 2018/412). All participants included in this study provided written informed consent after oral and written information. We confirm that we have read the Journal&#8217;s position on issues involved in ethical publication and affirm that this work is consistent with those guidelines.</p></notes></notes><ref-list id="Bib1"><title>References</title><ref id="CR1"><label>1.</label><citation-alternatives><element-citation id="ec-CR1" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Alves</surname><given-names>G</given-names></name><name name-style="western"><surname>Wentzel-Larsen</surname><given-names>T</given-names></name><name name-style="western"><surname>Aarsland</surname><given-names>D</given-names></name><name name-style="western"><surname>Larsen</surname><given-names>JP</given-names></name></person-group><article-title>Progression of motor impairment and disability in Parkinson disease: a population-based study</article-title><source>Neurology</source><year>2005</year><volume>65</volume><fpage>1436</fpage><lpage>1441</lpage><pub-id pub-id-type="pmid">16275832</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1212/01.wnl.0000183359.50822.f2</pub-id></element-citation><mixed-citation id="mc-CR1" publication-type="journal">Alves G, Wentzel-Larsen T, Aarsland D, Larsen JP (2005) Progression of motor impairment and disability in Parkinson disease: a population-based study. Neurology 65:1436&#8211;1441<pub-id pub-id-type="pmid">16275832</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1212/01.wnl.0000183359.50822.f2</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR2"><label>2.</label><citation-alternatives><element-citation id="ec-CR2" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Armstrong</surname><given-names>MJ</given-names></name><name name-style="western"><surname>Okun</surname><given-names>MS</given-names></name></person-group><article-title>Diagnosis and treatment of Parkinson disease: a review</article-title><source>JAMA</source><year>2020</year><volume>323</volume><fpage>548</fpage><lpage>560</lpage><pub-id pub-id-type="pmid">32044947</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1001/jama.2019.22360</pub-id></element-citation><mixed-citation id="mc-CR2" publication-type="journal">Armstrong MJ, Okun MS (2020) Diagnosis and treatment of Parkinson disease: a review. JAMA 323:548&#8211;560<pub-id pub-id-type="pmid">32044947</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1001/jama.2019.22360</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR3"><label>3.</label><citation-alternatives><element-citation id="ec-CR3" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Backer</surname><given-names>JH</given-names></name></person-group><article-title>The symptom experience of patients with Parkinson's disease</article-title><source>J Neurosci Nurs</source><year>2006</year><volume>38</volume><fpage>51</fpage><lpage>57</lpage><pub-id pub-id-type="pmid">16568814</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1097/01376517-200602000-00010</pub-id></element-citation><mixed-citation id="mc-CR3" publication-type="journal">Backer JH (2006) The symptom experience of patients with Parkinson&#8217;s disease. J Neurosci Nurs 38:51&#8211;57<pub-id pub-id-type="pmid">16568814</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1097/01376517-200602000-00010</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR4"><label>4.</label><citation-alternatives><element-citation id="ec-CR4" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bladh</surname><given-names>S</given-names></name><name name-style="western"><surname>Nilsson</surname><given-names>MH</given-names></name><name name-style="western"><surname>Hariz</surname><given-names>GM</given-names></name><name name-style="western"><surname>Westergren</surname><given-names>A</given-names></name><name name-style="western"><surname>Hobart</surname><given-names>J</given-names></name><name name-style="western"><surname>Hagell</surname><given-names>P</given-names></name></person-group><article-title>Psychometric performance of a generic walking scale (Walk-12G) in multiple sclerosis and Parkinson's disease</article-title><source>J Neurol</source><year>2012</year><volume>259</volume><fpage>729</fpage><lpage>738</lpage><pub-id pub-id-type="pmid">21956376</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s00415-011-6254-z</pub-id></element-citation><mixed-citation id="mc-CR4" publication-type="journal">Bladh S, Nilsson MH, Hariz GM, Westergren A, Hobart J, Hagell P (2012) Psychometric performance of a generic walking scale (Walk-12G) in multiple sclerosis and Parkinson&#8217;s disease. J Neurol 259:729&#8211;738<pub-id pub-id-type="pmid">21956376</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s00415-011-6254-z</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR5"><label>5.</label><citation-alternatives><element-citation id="ec-CR5" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bloem</surname><given-names>BR</given-names></name><name name-style="western"><surname>Beckley</surname><given-names>DJ</given-names></name><name name-style="western"><surname>van Dijk</surname><given-names>JG</given-names></name><name name-style="western"><surname>Zwinderman</surname><given-names>AH</given-names></name><name name-style="western"><surname>Remler</surname><given-names>MP</given-names></name><name name-style="western"><surname>Roos</surname><given-names>RA</given-names></name></person-group><article-title>Influence of dopaminergic medication on automatic postural responses and balance impairment in Parkinson's disease</article-title><source>Mov Disord</source><year>1996</year><volume>11</volume><fpage>509</fpage><lpage>521</lpage><pub-id pub-id-type="pmid">8866492</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/mds.870110506</pub-id></element-citation><mixed-citation id="mc-CR5" publication-type="journal">Bloem BR, Beckley DJ, van Dijk JG, Zwinderman AH, Remler MP, Roos RA (1996) Influence of dopaminergic medication on automatic postural responses and balance impairment in Parkinson&#8217;s disease. Mov Disord 11:509&#8211;521<pub-id pub-id-type="pmid">8866492</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/mds.870110506</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR6"><label>6.</label><citation-alternatives><element-citation id="ec-CR6" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Camacho-Soto</surname><given-names>A</given-names></name><name name-style="western"><surname>Gross</surname><given-names>A</given-names></name><name name-style="western"><surname>Searles Nielsen</surname><given-names>S</given-names></name><name name-style="western"><surname>Miller</surname><given-names>AN</given-names></name><name name-style="western"><surname>Warden</surname><given-names>MN</given-names></name><name name-style="western"><surname>Salter</surname><given-names>A</given-names></name><name name-style="western"><surname>Racette</surname><given-names>BA</given-names></name></person-group><article-title>Fractures in the prodromal period of Parkinson disease</article-title><source>Neurology</source><year>2020</year><volume>94</volume><fpage>e2448</fpage><lpage>e2456</lpage><pub-id pub-id-type="pmid">32345729</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1212/WNL.0000000000009452</pub-id><pub-id pub-id-type="pmcid">PMC7455361</pub-id></element-citation><mixed-citation id="mc-CR6" publication-type="journal">Camacho-Soto A, Gross A, Searles Nielsen S, Miller AN, Warden MN, Salter A, Racette BA (2020) Fractures in the prodromal period of Parkinson disease. Neurology 94:e2448&#8211;e2456<pub-id pub-id-type="pmid">32345729</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1212/WNL.0000000000009452</pub-id><pub-id pub-id-type="pmcid">PMC7455361</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR7"><label>7.</label><citation-alternatives><element-citation id="ec-CR7" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Camicioli</surname><given-names>R</given-names></name><name name-style="western"><surname>Morris</surname><given-names>ME</given-names></name><name name-style="western"><surname>Pieruccini-Faria</surname><given-names>F</given-names></name><name name-style="western"><surname>Montero-Odasso</surname><given-names>M</given-names></name><name name-style="western"><surname>Son</surname><given-names>S</given-names></name><name name-style="western"><surname>Buzaglo</surname><given-names>D</given-names></name><name name-style="western"><surname>Hausdorff</surname><given-names>JM</given-names></name><name name-style="western"><surname>Nieuwboer</surname><given-names>A</given-names></name></person-group><article-title>Prevention of falls in Parkinson's disease: guidelines and gaps</article-title><source>Mov Disord Clin Pract</source><year>2023</year><volume>10</volume><fpage>1459</fpage><lpage>1469</lpage><pub-id pub-id-type="pmid">37868930</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/mdc3.13860</pub-id><pub-id pub-id-type="pmcid">PMC10585979</pub-id></element-citation><mixed-citation id="mc-CR7" publication-type="journal">Camicioli R, Morris ME, Pieruccini-Faria F, Montero-Odasso M, Son S, Buzaglo D, Hausdorff JM, Nieuwboer A (2023) Prevention of falls in Parkinson&#8217;s disease: guidelines and gaps. Mov Disord Clin Pract 10:1459&#8211;1469<pub-id pub-id-type="pmid">37868930</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/mdc3.13860</pub-id><pub-id pub-id-type="pmcid">PMC10585979</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR8"><label>8.</label><citation-alternatives><element-citation id="ec-CR8" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Canning</surname><given-names>CG</given-names></name><name name-style="western"><surname>Sherrington</surname><given-names>C</given-names></name><name name-style="western"><surname>Lord</surname><given-names>SR</given-names></name><name name-style="western"><surname>Close</surname><given-names>JC</given-names></name><name name-style="western"><surname>Heritier</surname><given-names>S</given-names></name><name name-style="western"><surname>Heller</surname><given-names>GZ</given-names></name><name name-style="western"><surname>Howard</surname><given-names>K</given-names></name><name name-style="western"><surname>Allen</surname><given-names>NE</given-names></name><name name-style="western"><surname>Latt</surname><given-names>MD</given-names></name><name name-style="western"><surname>Murray</surname><given-names>SM</given-names></name><name name-style="western"><surname>O'Rourke</surname><given-names>SD</given-names></name><name name-style="western"><surname>Paul</surname><given-names>SS</given-names></name><name name-style="western"><surname>Song</surname><given-names>J</given-names></name><name name-style="western"><surname>Fung</surname><given-names>VS</given-names></name></person-group><article-title>Exercise for falls prevention in Parkinson disease: a randomized controlled trial</article-title><source>Neurology</source><year>2015</year><volume>84</volume><fpage>304</fpage><lpage>312</lpage><pub-id pub-id-type="pmid">25552576</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1212/WNL.0000000000001155</pub-id><pub-id pub-id-type="pmcid">PMC4335992</pub-id></element-citation><mixed-citation id="mc-CR8" publication-type="journal">Canning CG, Sherrington C, Lord SR, Close JC, Heritier S, Heller GZ, Howard K, Allen NE, Latt MD, Murray SM, O&#8217;Rourke SD, Paul SS, Song J, Fung VS (2015) Exercise for falls prevention in Parkinson disease: a randomized controlled trial. Neurology 84:304&#8211;312<pub-id pub-id-type="pmid">25552576</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1212/WNL.0000000000001155</pub-id><pub-id pub-id-type="pmcid">PMC4335992</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR9"><label>9.</label><citation-alternatives><element-citation id="ec-CR9" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cenci</surname><given-names>MA</given-names></name><name name-style="western"><surname>Riggare</surname><given-names>S</given-names></name><name name-style="western"><surname>Pahwa</surname><given-names>R</given-names></name><name name-style="western"><surname>Eidelberg</surname><given-names>D</given-names></name><name name-style="western"><surname>Hauser</surname><given-names>RA</given-names></name></person-group><article-title>Dyskinesia matters</article-title><source>Mov Disord</source><year>2020</year><volume>35</volume><fpage>392</fpage><lpage>396</lpage><pub-id pub-id-type="pmid">31872501</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/mds.27959</pub-id></element-citation><mixed-citation id="mc-CR9" publication-type="journal">Cenci MA, Riggare S, Pahwa R, Eidelberg D, Hauser RA (2020) Dyskinesia matters. Mov Disord 35:392&#8211;396<pub-id pub-id-type="pmid">31872501</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/mds.27959</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR10"><label>10.</label><citation-alternatives><element-citation id="ec-CR10" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dalrymple-Alford</surname><given-names>JC</given-names></name><name name-style="western"><surname>MacAskill</surname><given-names>MR</given-names></name><name name-style="western"><surname>Nakas</surname><given-names>CT</given-names></name><name name-style="western"><surname>Livingston</surname><given-names>L</given-names></name><name name-style="western"><surname>Graham</surname><given-names>C</given-names></name><name name-style="western"><surname>Crucian</surname><given-names>GP</given-names></name><name name-style="western"><surname>Melzer</surname><given-names>TR</given-names></name><name name-style="western"><surname>Kirwan</surname><given-names>J</given-names></name><name name-style="western"><surname>Keenan</surname><given-names>R</given-names></name><name name-style="western"><surname>Wells</surname><given-names>S</given-names></name><name name-style="western"><surname>Porter</surname><given-names>RJ</given-names></name><name name-style="western"><surname>Watts</surname><given-names>R</given-names></name><name name-style="western"><surname>Anderson</surname><given-names>TJ</given-names></name></person-group><article-title>The MoCA: well-suited screen for cognitive impairment in Parkinson disease</article-title><source>Neurology</source><year>2010</year><volume>75</volume><fpage>1717</fpage><lpage>1725</lpage><pub-id pub-id-type="pmid">21060094</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1212/WNL.0b013e3181fc29c9</pub-id></element-citation><mixed-citation id="mc-CR10" publication-type="journal">Dalrymple-Alford JC, MacAskill MR, Nakas CT, Livingston L, Graham C, Crucian GP, Melzer TR, Kirwan J, Keenan R, Wells S, Porter RJ, Watts R, Anderson TJ (2010) The MoCA: well-suited screen for cognitive impairment in Parkinson disease. Neurology 75:1717&#8211;1725<pub-id pub-id-type="pmid">21060094</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1212/WNL.0b013e3181fc29c9</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR11"><label>11.</label><citation-alternatives><element-citation id="ec-CR11" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Debu</surname><given-names>B</given-names></name><name name-style="western"><surname>De Oliveira</surname><given-names>GC</given-names></name><name name-style="western"><surname>Lino</surname><given-names>JC</given-names></name><name name-style="western"><surname>Moro</surname><given-names>E</given-names></name></person-group><article-title>Managing gait, balance, and posture in Parkinson's disease</article-title><source>Curr Neurol Neurosci Rep</source><year>2018</year><volume>18</volume><fpage>23</fpage><pub-id pub-id-type="pmid">29623455</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s11910-018-0828-4</pub-id></element-citation><mixed-citation id="mc-CR11" publication-type="journal">Debu B, De Oliveira GC, Lino JC, Moro E (2018) Managing gait, balance, and posture in Parkinson&#8217;s disease. Curr Neurol Neurosci Rep 18:23<pub-id pub-id-type="pmid">29623455</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s11910-018-0828-4</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR12"><label>12.</label><citation-alternatives><element-citation id="ec-CR12" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Di Lazzaro</surname><given-names>G</given-names></name><name name-style="western"><surname>Ricci</surname><given-names>M</given-names></name><name name-style="western"><surname>Al-Wardat</surname><given-names>M</given-names></name><name name-style="western"><surname>Schirinzi</surname><given-names>T</given-names></name><name name-style="western"><surname>Scalise</surname><given-names>S</given-names></name><name name-style="western"><surname>Giannini</surname><given-names>F</given-names></name><name name-style="western"><surname>Mercuri</surname><given-names>NB</given-names></name><name name-style="western"><surname>Saggio</surname><given-names>G</given-names></name><name name-style="western"><surname>Pisani</surname><given-names>A</given-names></name></person-group><article-title>Technology-based objective measures detect subclinical axial signs in untreated, de novo Parkinson's disease</article-title><source>J Parkinsons Dis</source><year>2020</year><volume>10</volume><fpage>113</fpage><lpage>122</lpage><pub-id pub-id-type="pmid">31594252</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3233/JPD-191758</pub-id></element-citation><mixed-citation id="mc-CR12" publication-type="journal">Di Lazzaro G, Ricci M, Al-Wardat M, Schirinzi T, Scalise S, Giannini F, Mercuri NB, Saggio G, Pisani A (2020) Technology-based objective measures detect subclinical axial signs in untreated, de novo Parkinson&#8217;s disease. J Parkinsons Dis 10:113&#8211;122<pub-id pub-id-type="pmid">31594252</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3233/JPD-191758</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR13"><label>13.</label><citation-alternatives><element-citation id="ec-CR13" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dubois</surname><given-names>B</given-names></name><name name-style="western"><surname>Slachevsky</surname><given-names>A</given-names></name><name name-style="western"><surname>Litvan</surname><given-names>I</given-names></name><name name-style="western"><surname>Pillon</surname><given-names>B</given-names></name></person-group><article-title>The FAB: a frontal assessment battery at bedside</article-title><source>Neurology</source><year>2000</year><volume>55</volume><fpage>1621</fpage><lpage>1626</lpage><pub-id pub-id-type="pmid">11113214</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1212/wnl.55.11.1621</pub-id></element-citation><mixed-citation id="mc-CR13" publication-type="journal">Dubois B, Slachevsky A, Litvan I, Pillon B (2000) The FAB: a frontal assessment battery at bedside. Neurology 55:1621&#8211;1626<pub-id pub-id-type="pmid">11113214</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1212/wnl.55.11.1621</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR14"><label>14.</label><citation-alternatives><element-citation id="ec-CR14" publication-type="book"><person-group person-group-type="author"><name name-style="western"><surname>Fahn</surname><given-names>S</given-names></name><name name-style="western"><surname>Elton</surname><given-names>R</given-names></name><etal/></person-group><person-group person-group-type="editor"><name name-style="western"><surname>Fahn</surname><given-names>S</given-names></name><name name-style="western"><surname>Marsden</surname><given-names>CD</given-names></name><name name-style="western"><surname>Calne</surname><given-names>D</given-names></name><name name-style="western"><surname>Goldstein</surname><given-names>M</given-names></name><etal/></person-group><article-title>Unified Parkinson's disease rating scale</article-title><source>Recent developments in Parkinson's disease</source><year>1987</year><publisher-loc>Florham Park, NJ</publisher-loc><publisher-name>McMillan Healthcare Information</publisher-name><fpage>153</fpage><lpage>163, 293&#8211;304</lpage></element-citation><mixed-citation id="mc-CR14" publication-type="book">Fahn S, Elton R et al (1987) Unified Parkinson&#8217;s disease rating scale. In: Fahn S, Marsden CD, Calne D, Goldstein M (eds) Recent developments in Parkinson&#8217;s disease. McMillan Healthcare Information, Florham Park, NJ, pp 153&#8211;163, 293&#8211;304</mixed-citation></citation-alternatives></ref><ref id="CR15"><label>15.</label><citation-alternatives><element-citation id="ec-CR15" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Feng</surname><given-names>YS</given-names></name><name name-style="western"><surname>Yang</surname><given-names>SD</given-names></name><name name-style="western"><surname>Tan</surname><given-names>ZX</given-names></name><name name-style="western"><surname>Wang</surname><given-names>MM</given-names></name><name name-style="western"><surname>Xing</surname><given-names>Y</given-names></name><name name-style="western"><surname>Dong</surname><given-names>F</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>F</given-names></name></person-group><article-title>The benefits and mechanisms of exercise training for Parkinson's disease</article-title><source>Life Sci</source><year>2020</year><volume>245</volume><fpage>117345</fpage><pub-id pub-id-type="pmid">31981631</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.lfs.2020.117345</pub-id></element-citation><mixed-citation id="mc-CR15" publication-type="journal">Feng YS, Yang SD, Tan ZX, Wang MM, Xing Y, Dong F, Zhang F (2020) The benefits and mechanisms of exercise training for Parkinson&#8217;s disease. Life Sci 245:117345<pub-id pub-id-type="pmid">31981631</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.lfs.2020.117345</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR16"><label>16.</label><citation-alternatives><element-citation id="ec-CR16" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Foltynie</surname><given-names>T</given-names></name><name name-style="western"><surname>Bruno</surname><given-names>V</given-names></name><name name-style="western"><surname>Fox</surname><given-names>S</given-names></name><name name-style="western"><surname>Kuhn</surname><given-names>AA</given-names></name><name name-style="western"><surname>Lindop</surname><given-names>F</given-names></name><name name-style="western"><surname>Lees</surname><given-names>AJ</given-names></name></person-group><article-title>Medical, surgical, and physical treatments for Parkinson's disease</article-title><source>Lancet</source><year>2024</year><volume>403</volume><fpage>305</fpage><lpage>324</lpage><pub-id pub-id-type="pmid">38245250</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/S0140-6736(23)01429-0</pub-id></element-citation><mixed-citation id="mc-CR16" publication-type="journal">Foltynie T, Bruno V, Fox S, Kuhn AA, Lindop F, Lees AJ (2024) Medical, surgical, and physical treatments for Parkinson&#8217;s disease. Lancet 403:305&#8211;324<pub-id pub-id-type="pmid">38245250</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/S0140-6736(23)01429-0</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR17"><label>17.</label><citation-alternatives><element-citation id="ec-CR17" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hagell</surname><given-names>P</given-names></name><name name-style="western"><surname>Nordling</surname><given-names>S</given-names></name><name name-style="western"><surname>Reimer</surname><given-names>J</given-names></name><name name-style="western"><surname>Grabowski</surname><given-names>M</given-names></name><name name-style="western"><surname>Persson</surname><given-names>U</given-names></name></person-group><article-title>Resource use and costs in a Swedish cohort of patients with Parkinson's disease</article-title><source>Mov Disord</source><year>2002</year><volume>17</volume><fpage>1213</fpage><lpage>1220</lpage><pub-id pub-id-type="pmid">12465059</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/mds.10262</pub-id></element-citation><mixed-citation id="mc-CR17" publication-type="journal">Hagell P, Nordling S, Reimer J, Grabowski M, Persson U (2002) Resource use and costs in a Swedish cohort of patients with Parkinson&#8217;s disease. Mov Disord 17:1213&#8211;1220<pub-id pub-id-type="pmid">12465059</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/mds.10262</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR18"><label>18.</label><citation-alternatives><element-citation id="ec-CR18" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hely</surname><given-names>MA</given-names></name><name name-style="western"><surname>Morris</surname><given-names>JG</given-names></name><name name-style="western"><surname>Traficante</surname><given-names>R</given-names></name><name name-style="western"><surname>Reid</surname><given-names>WG</given-names></name><name name-style="western"><surname>O'Sullivan</surname><given-names>DJ</given-names></name><name name-style="western"><surname>Williamson</surname><given-names>PM</given-names></name></person-group><article-title>The sydney multicentre study of Parkinson's disease: progression and mortality at 10 years</article-title><source>J Neurol Neurosurg Psychiatry</source><year>1999</year><volume>67</volume><fpage>300</fpage><lpage>307</lpage><pub-id pub-id-type="pmid">10449550</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1136/jnnp.67.3.300</pub-id><pub-id pub-id-type="pmcid">PMC1736543</pub-id></element-citation><mixed-citation id="mc-CR18" publication-type="journal">Hely MA, Morris JG, Traficante R, Reid WG, O&#8217;Sullivan DJ, Williamson PM (1999) The sydney multicentre study of Parkinson&#8217;s disease: progression and mortality at 10 years. J Neurol Neurosurg Psychiatry 67:300&#8211;307<pub-id pub-id-type="pmid">10449550</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1136/jnnp.67.3.300</pub-id><pub-id pub-id-type="pmcid">PMC1736543</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR19"><label>19.</label><citation-alternatives><element-citation id="ec-CR19" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hjalte</surname><given-names>F</given-names></name><name name-style="western"><surname>Norlin</surname><given-names>JM</given-names></name><name name-style="western"><surname>Kellerborg</surname><given-names>K</given-names></name><name name-style="western"><surname>Odin</surname><given-names>P</given-names></name></person-group><article-title>Parkinson's disease in Sweden-resource use and costs by severity</article-title><source>Acta Neurol Scand</source><year>2021</year><volume>144</volume><fpage>592</fpage><lpage>599</lpage><pub-id pub-id-type="pmid">34254292</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/ane.13502</pub-id></element-citation><mixed-citation id="mc-CR19" publication-type="journal">Hjalte F, Norlin JM, Kellerborg K, Odin P (2021) Parkinson&#8217;s disease in Sweden-resource use and costs by severity. Acta Neurol Scand 144:592&#8211;599<pub-id pub-id-type="pmid">34254292</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/ane.13502</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR20"><label>20.</label><citation-alternatives><element-citation id="ec-CR20" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hjelmgren</surname><given-names>J</given-names></name><name name-style="western"><surname>Ghatnekar</surname><given-names>O</given-names></name><name name-style="western"><surname>Reimer</surname><given-names>J</given-names></name><name name-style="western"><surname>Grabowski</surname><given-names>M</given-names></name><name name-style="western"><surname>Lindvall</surname><given-names>O</given-names></name><name name-style="western"><surname>Persson</surname><given-names>U</given-names></name><name name-style="western"><surname>Hagell</surname><given-names>P</given-names></name></person-group><article-title>Estimating the value of novel interventions for Parkinson's disease: an early decision-making model with application to dopamine cell replacement</article-title><source>Parkinsonism Relat Disord</source><year>2006</year><volume>12</volume><fpage>443</fpage><lpage>452</lpage><pub-id pub-id-type="pmid">16798054</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.parkreldis.2006.04.006</pub-id></element-citation><mixed-citation id="mc-CR20" publication-type="journal">Hjelmgren J, Ghatnekar O, Reimer J, Grabowski M, Lindvall O, Persson U, Hagell P (2006) Estimating the value of novel interventions for Parkinson&#8217;s disease: an early decision-making model with application to dopamine cell replacement. Parkinsonism Relat Disord 12:443&#8211;452<pub-id pub-id-type="pmid">16798054</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.parkreldis.2006.04.006</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR21"><label>21.</label><citation-alternatives><element-citation id="ec-CR21" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hoehn</surname><given-names>MM</given-names></name><name name-style="western"><surname>Yahr</surname><given-names>MD</given-names></name></person-group><article-title>Parkinsonism: onset, progression, and mortality</article-title><source>Neurology</source><year>2001</year><volume>57</volume><fpage>S11</fpage><lpage>26</lpage><pub-id pub-id-type="pmid">11775596</pub-id></element-citation><mixed-citation id="mc-CR21" publication-type="journal">Hoehn MM, Yahr MD (2001) Parkinsonism: onset, progression, and mortality. Neurology 57:S11-26<pub-id pub-id-type="pmid">11775596</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR22"><label>22.</label><citation-alternatives><element-citation id="ec-CR22" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Horak</surname><given-names>FB</given-names></name><name name-style="western"><surname>Dimitrova</surname><given-names>D</given-names></name><name name-style="western"><surname>Nutt</surname><given-names>JG</given-names></name></person-group><article-title>Direction-specific postural instability in subjects with Parkinson's disease</article-title><source>Exp Neurol</source><year>2005</year><volume>193</volume><fpage>504</fpage><lpage>521</lpage><pub-id pub-id-type="pmid">15869953</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.expneurol.2004.12.008</pub-id></element-citation><mixed-citation id="mc-CR22" publication-type="journal">Horak FB, Dimitrova D, Nutt JG (2005) Direction-specific postural instability in subjects with Parkinson&#8217;s disease. Exp Neurol 193:504&#8211;521<pub-id pub-id-type="pmid">15869953</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.expneurol.2004.12.008</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR23"><label>23.</label><citation-alternatives><element-citation id="ec-CR23" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Horak</surname><given-names>FB</given-names></name><name name-style="western"><surname>Frank</surname><given-names>J</given-names></name><name name-style="western"><surname>Nutt</surname><given-names>J</given-names></name></person-group><article-title>Effects of dopamine on postural control in parkinsonian subjects: scaling, set, and tone</article-title><source>J Neurophysiol</source><year>1996</year><volume>75</volume><fpage>2380</fpage><lpage>2396</lpage><pub-id pub-id-type="pmid">8793751</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1152/jn.1996.75.6.2380</pub-id></element-citation><mixed-citation id="mc-CR23" publication-type="journal">Horak FB, Frank J, Nutt J (1996) Effects of dopamine on postural control in parkinsonian subjects: scaling, set, and tone. J Neurophysiol 75:2380&#8211;2396<pub-id pub-id-type="pmid">8793751</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1152/jn.1996.75.6.2380</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR24"><label>24.</label><citation-alternatives><element-citation id="ec-CR24" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hughes</surname><given-names>AJ</given-names></name><name name-style="western"><surname>Daniel</surname><given-names>SE</given-names></name><name name-style="western"><surname>Kilford</surname><given-names>L</given-names></name><name name-style="western"><surname>Lees</surname><given-names>AJ</given-names></name></person-group><article-title>Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases</article-title><source>J Neurol Neurosurg Psychiatry</source><year>1992</year><volume>55</volume><fpage>181</fpage><lpage>184</lpage><pub-id pub-id-type="pmid">1564476</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1136/jnnp.55.3.181</pub-id><pub-id pub-id-type="pmcid">PMC1014720</pub-id></element-citation><mixed-citation id="mc-CR24" publication-type="journal">Hughes AJ, Daniel SE, Kilford L, Lees AJ (1992) Accuracy of clinical diagnosis of idiopathic Parkinson&#8217;s disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 55:181&#8211;184<pub-id pub-id-type="pmid">1564476</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1136/jnnp.55.3.181</pub-id><pub-id pub-id-type="pmcid">PMC1014720</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR25"><label>25.</label><citation-alternatives><element-citation id="ec-CR25" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hulzinga</surname><given-names>F</given-names></name><name name-style="western"><surname>de Rond</surname><given-names>V</given-names></name><name name-style="western"><surname>Vandendoorent</surname><given-names>B</given-names></name><name name-style="western"><surname>Gilat</surname><given-names>M</given-names></name><name name-style="western"><surname>Ginis</surname><given-names>P</given-names></name><name name-style="western"><surname>D'Cruz</surname><given-names>N</given-names></name><name name-style="western"><surname>Schlenstedt</surname><given-names>C</given-names></name><name name-style="western"><surname>Nieuwboer</surname><given-names>A</given-names></name></person-group><article-title>Repeated gait perturbation training in Parkinson's disease and healthy older adults: a systematic review and meta-analysis</article-title><source>Front Hum Neurosci</source><year>2021</year><volume>15</volume><fpage>732648</fpage><pub-id pub-id-type="pmid">34764860</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3389/fnhum.2021.732648</pub-id><pub-id pub-id-type="pmcid">PMC8576267</pub-id></element-citation><mixed-citation id="mc-CR25" publication-type="journal">Hulzinga F, de Rond V, Vandendoorent B, Gilat M, Ginis P, D&#8217;Cruz N, Schlenstedt C, Nieuwboer A (2021) Repeated gait perturbation training in Parkinson&#8217;s disease and healthy older adults: a systematic review and meta-analysis. Front Hum Neurosci 15:732648<pub-id pub-id-type="pmid">34764860</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3389/fnhum.2021.732648</pub-id><pub-id pub-id-type="pmcid">PMC8576267</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR26"><label>26.</label><citation-alternatives><element-citation id="ec-CR26" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jankovic</surname><given-names>J</given-names></name><name name-style="western"><surname>McDermott</surname><given-names>M</given-names></name><name name-style="western"><surname>Carter</surname><given-names>J</given-names></name><name name-style="western"><surname>Gauthier</surname><given-names>S</given-names></name><name name-style="western"><surname>Goetz</surname><given-names>C</given-names></name><name name-style="western"><surname>Golbe</surname><given-names>L</given-names></name><name name-style="western"><surname>Huber</surname><given-names>S</given-names></name><name name-style="western"><surname>Koller</surname><given-names>W</given-names></name><name name-style="western"><surname>Olanow</surname><given-names>C</given-names></name><name name-style="western"><surname>Shoulson</surname><given-names>I</given-names></name><etal/></person-group><article-title>Variable expression of Parkinson's disease: a base-line analysis of the DATATOP cohort: the Parkinson study group</article-title><source>Neurology</source><year>1990</year><volume>40</volume><fpage>1529</fpage><lpage>1534</lpage><pub-id pub-id-type="pmid">2215943</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1212/wnl.40.10.1529</pub-id></element-citation><mixed-citation id="mc-CR26" publication-type="journal">Jankovic J, McDermott M, Carter J, Gauthier S, Goetz C, Golbe L, Huber S, Koller W, Olanow C, Shoulson I et al (1990) Variable expression of Parkinson&#8217;s disease: a base-line analysis of the DATATOP cohort: the Parkinson study group. Neurology 40:1529&#8211;1534<pub-id pub-id-type="pmid">2215943</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1212/wnl.40.10.1529</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR27"><label>27.</label><citation-alternatives><element-citation id="ec-CR27" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jeong</surname><given-names>SH</given-names></name><name name-style="western"><surname>Park</surname><given-names>CW</given-names></name><name name-style="western"><surname>Lee</surname><given-names>HS</given-names></name><name name-style="western"><surname>Kim</surname><given-names>YJ</given-names></name><name name-style="western"><surname>Yun</surname><given-names>M</given-names></name><name name-style="western"><surname>Lee</surname><given-names>PH</given-names></name><name name-style="western"><surname>Sohn</surname><given-names>YH</given-names></name><name name-style="western"><surname>Chung</surname><given-names>SJ</given-names></name></person-group><article-title>Patterns of striatal dopamine depletion and motor deficits in de novo Parkinson's disease</article-title><source>J Neural Transm (Vienna)</source><year>2023</year><volume>130</volume><fpage>19</fpage><lpage>28</lpage><pub-id pub-id-type="pmid">36462096</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s00702-022-02571-9</pub-id></element-citation><mixed-citation id="mc-CR27" publication-type="journal">Jeong SH, Park CW, Lee HS, Kim YJ, Yun M, Lee PH, Sohn YH, Chung SJ (2023) Patterns of striatal dopamine depletion and motor deficits in de novo Parkinson&#8217;s disease. J Neural Transm (Vienna) 130:19&#8211;28<pub-id pub-id-type="pmid">36462096</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s00702-022-02571-9</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR28"><label>28.</label><citation-alternatives><element-citation id="ec-CR28" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Johansson</surname><given-names>C</given-names></name><name name-style="western"><surname>Lindstrom</surname><given-names>B</given-names></name><name name-style="western"><surname>Forsgren</surname><given-names>L</given-names></name><name name-style="western"><surname>Johansson</surname><given-names>GM</given-names></name></person-group><article-title>Balance and mobility in patients with newly diagnosed Parkinson's disease: a five-year follow-up of a cohort in northern Sweden</article-title><source>Disabil Rehabil</source><year>2020</year><volume>42</volume><fpage>770</fpage><lpage>778</lpage><pub-id pub-id-type="pmid">30451551</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1080/09638288.2018.1509240</pub-id></element-citation><mixed-citation id="mc-CR28" publication-type="journal">Johansson C, Lindstrom B, Forsgren L, Johansson GM (2020) Balance and mobility in patients with newly diagnosed Parkinson&#8217;s disease: a five-year follow-up of a cohort in northern Sweden. Disabil Rehabil 42:770&#8211;778<pub-id pub-id-type="pmid">30451551</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1080/09638288.2018.1509240</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR29"><label>29.</label><citation-alternatives><element-citation id="ec-CR29" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kamieniarz</surname><given-names>A</given-names></name><name name-style="western"><surname>Michalska</surname><given-names>J</given-names></name><name name-style="western"><surname>Marszalek</surname><given-names>W</given-names></name><name name-style="western"><surname>Stania</surname><given-names>M</given-names></name><name name-style="western"><surname>Slomka</surname><given-names>KJ</given-names></name><name name-style="western"><surname>Gorzkowska</surname><given-names>A</given-names></name><name name-style="western"><surname>Juras</surname><given-names>G</given-names></name><name name-style="western"><surname>Okun</surname><given-names>MS</given-names></name><name name-style="western"><surname>Christou</surname><given-names>EA</given-names></name></person-group><article-title>Detection of postural control in early Parkinson's disease: clinical testing vs modulation of center of pressure</article-title><source>PLoS ONE</source><year>2021</year><volume>16</volume><fpage>e0245353</fpage><pub-id pub-id-type="pmid">33434235</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1371/journal.pone.0245353</pub-id><pub-id pub-id-type="pmcid">PMC7802937</pub-id></element-citation><mixed-citation id="mc-CR29" publication-type="journal">Kamieniarz A, Michalska J, Marszalek W, Stania M, Slomka KJ, Gorzkowska A, Juras G, Okun MS, Christou EA (2021) Detection of postural control in early Parkinson&#8217;s disease: clinical testing vs modulation of center of pressure. PLoS ONE 16:e0245353<pub-id pub-id-type="pmid">33434235</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1371/journal.pone.0245353</pub-id><pub-id pub-id-type="pmcid">PMC7802937</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR30"><label>30.</label><citation-alternatives><element-citation id="ec-CR30" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kawami</surname><given-names>Y</given-names></name><name name-style="western"><surname>Nikaido</surname><given-names>Y</given-names></name><name name-style="western"><surname>Nose</surname><given-names>S</given-names></name><name name-style="western"><surname>Unekawa</surname><given-names>M</given-names></name><name name-style="western"><surname>Marumoto</surname><given-names>K</given-names></name><name name-style="western"><surname>Kawami</surname><given-names>M</given-names></name><name name-style="western"><surname>Matsugashita</surname><given-names>S</given-names></name><name name-style="western"><surname>Kozuki</surname><given-names>T</given-names></name><name name-style="western"><surname>Akisue</surname><given-names>T</given-names></name></person-group><article-title>Mediolateral postural control during gait in Parkinson's disease</article-title><source>Prog Rehabil Med</source><year>2022</year><volume>7</volume><fpage>20220048</fpage><pub-id pub-id-type="pmid">36160027</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.2490/prm.20220048</pub-id><pub-id pub-id-type="pmcid">PMC9470496</pub-id></element-citation><mixed-citation id="mc-CR30" publication-type="journal">Kawami Y, Nikaido Y, Nose S, Unekawa M, Marumoto K, Kawami M, Matsugashita S, Kozuki T, Akisue T (2022) Mediolateral postural control during gait in Parkinson&#8217;s disease. Prog Rehabil Med 7:20220048<pub-id pub-id-type="pmid">36160027</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.2490/prm.20220048</pub-id><pub-id pub-id-type="pmcid">PMC9470496</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR31"><label>31.</label><citation-alternatives><element-citation id="ec-CR31" publication-type="book"><person-group person-group-type="author"><name name-style="western"><surname>Keus</surname><given-names>S</given-names></name><name name-style="western"><surname>Munneke</surname><given-names>M</given-names></name><name name-style="western"><surname>Graziano</surname><given-names>M</given-names></name><name name-style="western"><surname>Paltamaa</surname><given-names>J</given-names></name><name name-style="western"><surname>Pelosin</surname><given-names>E</given-names></name><name name-style="western"><surname>Domingos</surname><given-names>J</given-names></name><etal/></person-group><source>European physiotherapy guideline for Parkinson&#8217;s disease</source><year>2014</year><publisher-loc>The Netherlands</publisher-loc><publisher-name>KNGF/ParkinsonNet</publisher-name></element-citation><mixed-citation id="mc-CR31" publication-type="book">Keus S, Munneke M, Graziano M, Paltamaa J, Pelosin E, Domingos J et al (2014) European physiotherapy guideline for Parkinson&#8217;s disease. KNGF/ParkinsonNet, The Netherlands</mixed-citation></citation-alternatives></ref><ref id="CR32"><label>32.</label><citation-alternatives><element-citation id="ec-CR32" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kwon</surname><given-names>KY</given-names></name><name name-style="western"><surname>Lee</surname><given-names>HM</given-names></name><name name-style="western"><surname>Kang</surname><given-names>SH</given-names></name><name name-style="western"><surname>Pyo</surname><given-names>SJ</given-names></name><name name-style="western"><surname>Kim</surname><given-names>HJ</given-names></name><name name-style="western"><surname>Koh</surname><given-names>SB</given-names></name></person-group><article-title>Recuperation of slow walking in de novo Parkinson's disease is more closely associated with increased cadence, rather than with expanded stride length</article-title><source>Gait Posture</source><year>2017</year><volume>58</volume><fpage>1</fpage><lpage>6</lpage><pub-id pub-id-type="pmid">28692855</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.gaitpost.2017.06.266</pub-id></element-citation><mixed-citation id="mc-CR32" publication-type="journal">Kwon KY, Lee HM, Kang SH, Pyo SJ, Kim HJ, Koh SB (2017) Recuperation of slow walking in de novo Parkinson&#8217;s disease is more closely associated with increased cadence, rather than with expanded stride length. Gait Posture 58:1&#8211;6<pub-id pub-id-type="pmid">28692855</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.gaitpost.2017.06.266</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR33"><label>33.</label><citation-alternatives><element-citation id="ec-CR33" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kwon</surname><given-names>KY</given-names></name><name name-style="western"><surname>Park</surname><given-names>S</given-names></name><name name-style="western"><surname>Kim</surname><given-names>RO</given-names></name><name name-style="western"><surname>Lee</surname><given-names>EJ</given-names></name><name name-style="western"><surname>Lee</surname><given-names>M</given-names></name></person-group><article-title>Associations of cognitive dysfunction with motor and non-motor symptoms in patients with de novo Parkinson's disease</article-title><source>Sci Rep</source><year>2022</year><volume>12</volume><fpage>11461</fpage><pub-id pub-id-type="pmid">35794147</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41598-022-15630-8</pub-id><pub-id pub-id-type="pmcid">PMC9259652</pub-id></element-citation><mixed-citation id="mc-CR33" publication-type="journal">Kwon KY, Park S, Kim RO, Lee EJ, Lee M (2022) Associations of cognitive dysfunction with motor and non-motor symptoms in patients with de novo Parkinson&#8217;s disease. Sci Rep 12:11461<pub-id pub-id-type="pmid">35794147</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41598-022-15630-8</pub-id><pub-id pub-id-type="pmcid">PMC9259652</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR34"><label>34.</label><citation-alternatives><element-citation id="ec-CR34" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lee</surname><given-names>SM</given-names></name><name name-style="western"><surname>Lee</surname><given-names>M</given-names></name><name name-style="western"><surname>Lee</surname><given-names>EJ</given-names></name><name name-style="western"><surname>Kim</surname><given-names>RO</given-names></name><name name-style="western"><surname>Kim</surname><given-names>Y</given-names></name><name name-style="western"><surname>Kwon</surname><given-names>KY</given-names></name></person-group><article-title>Association between gait and dysautonomia in patients with de novo Parkinson's disease: forward gait versus backward gait</article-title><source>J Mov Disord</source><year>2023</year><volume>16</volume><fpage>59</fpage><lpage>67</lpage><pub-id pub-id-type="pmid">36065616</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.14802/jmd.22045</pub-id><pub-id pub-id-type="pmcid">PMC9978258</pub-id></element-citation><mixed-citation id="mc-CR34" publication-type="journal">Lee SM, Lee M, Lee EJ, Kim RO, Kim Y, Kwon KY (2023) Association between gait and dysautonomia in patients with de novo Parkinson&#8217;s disease: forward gait versus backward gait. J Mov Disord 16:59&#8211;67<pub-id pub-id-type="pmid">36065616</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.14802/jmd.22045</pub-id><pub-id pub-id-type="pmcid">PMC9978258</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR35"><label>35.</label><citation-alternatives><element-citation id="ec-CR35" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lima</surname><given-names>DP</given-names></name><name name-style="western"><surname>de-Almeida</surname><given-names>SB</given-names></name><name name-style="western"><surname>Bonfadini</surname><given-names>JC</given-names></name><name name-style="western"><surname>Carneiro</surname><given-names>AHS</given-names></name><name name-style="western"><surname>de Luna</surname><given-names>JRG</given-names></name><name name-style="western"><surname>de Alencar</surname><given-names>MS</given-names></name><name name-style="western"><surname>Viana-Junior</surname><given-names>AB</given-names></name><name name-style="western"><surname>Rodrigues</surname><given-names>PGB</given-names></name><name name-style="western"><surname>Pereira</surname><given-names>IS</given-names></name><name name-style="western"><surname>Roriz-Filho</surname><given-names>JS</given-names></name><name name-style="western"><surname>Sobreira-Neto</surname><given-names>MA</given-names></name><name name-style="western"><surname>Braga-Neto</surname><given-names>P</given-names></name></person-group><article-title>Falls in Parkinson's disease: the impact of disease progression, treatment, and motor complications</article-title><source>Dement Neuropsychol</source><year>2022</year><volume>16</volume><fpage>153</fpage><lpage>161</lpage><pub-id pub-id-type="pmid">35720647</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1590/1980-5764-DN-2021-0019</pub-id><pub-id pub-id-type="pmcid">PMC9173793</pub-id></element-citation><mixed-citation id="mc-CR35" publication-type="journal">Lima DP, de-Almeida SB, Bonfadini JC, Carneiro AHS, de Luna JRG, de Alencar MS, Viana-Junior AB, Rodrigues PGB, Pereira IS, Roriz-Filho JS, Sobreira-Neto MA, Braga-Neto P (2022) Falls in Parkinson&#8217;s disease: the impact of disease progression, treatment, and motor complications. Dement Neuropsychol 16:153&#8211;161<pub-id pub-id-type="pmid">35720647</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1590/1980-5764-DN-2021-0019</pub-id><pub-id pub-id-type="pmcid">PMC9173793</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR36"><label>36.</label><citation-alternatives><element-citation id="ec-CR36" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lindholm</surname><given-names>B</given-names></name><name name-style="western"><surname>Beckman</surname><given-names>A</given-names></name><name name-style="western"><surname>Duzynski</surname><given-names>W</given-names></name><name name-style="western"><surname>Ekvall Hansson</surname><given-names>E</given-names></name></person-group><article-title>Outcome on balance and gait following botulinum toxin treatment for striatal foot in Parkinson's disease</article-title><source>Mov Disord Clin Pract</source><year>2017</year><volume>4</volume><fpage>309</fpage><lpage>315</lpage><pub-id pub-id-type="pmid">30363465</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/mdc3.12411</pub-id><pub-id pub-id-type="pmcid">PMC6174462</pub-id></element-citation><mixed-citation id="mc-CR36" publication-type="journal">Lindholm B, Beckman A, Duzynski W, Ekvall Hansson E (2017) Outcome on balance and gait following botulinum toxin treatment for striatal foot in Parkinson&#8217;s disease. Mov Disord Clin Pract 4:309&#8211;315<pub-id pub-id-type="pmid">30363465</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/mdc3.12411</pub-id><pub-id pub-id-type="pmcid">PMC6174462</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR37"><label>37.</label><citation-alternatives><element-citation id="ec-CR37" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lindholm</surname><given-names>B</given-names></name><name name-style="western"><surname>Brogardh</surname><given-names>C</given-names></name><name name-style="western"><surname>Odin</surname><given-names>P</given-names></name><name name-style="western"><surname>Hagell</surname><given-names>P</given-names></name></person-group><article-title>Longitudinal prediction of falls and near falls frequencies in Parkinson's disease: a prospective cohort study</article-title><source>J Neurol</source><year>2021</year><volume>268</volume><fpage>997</fpage><lpage>1005</lpage><pub-id pub-id-type="pmid">32970193</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s00415-020-10234-6</pub-id><pub-id pub-id-type="pmcid">PMC7914172</pub-id></element-citation><mixed-citation id="mc-CR37" publication-type="journal">Lindholm B, Brogardh C, Odin P, Hagell P (2021) Longitudinal prediction of falls and near falls frequencies in Parkinson&#8217;s disease: a prospective cohort study. J Neurol 268:997&#8211;1005<pub-id pub-id-type="pmid">32970193</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s00415-020-10234-6</pub-id><pub-id pub-id-type="pmcid">PMC7914172</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR38"><label>38.</label><citation-alternatives><element-citation id="ec-CR38" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lindholm</surname><given-names>B</given-names></name><name name-style="western"><surname>Eek</surname><given-names>F</given-names></name><name name-style="western"><surname>Skogar</surname><given-names>O</given-names></name><name name-style="western"><surname>Hansson</surname><given-names>EE</given-names></name></person-group><article-title>Dyskinesia and FAB score predict future falling in Parkinson's disease</article-title><source>Acta Neurol Scand</source><year>2019</year><volume>139</volume><fpage>512</fpage><lpage>518</lpage><pub-id pub-id-type="pmid">30820932</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/ane.13084</pub-id></element-citation><mixed-citation id="mc-CR38" publication-type="journal">Lindholm B, Eek F, Skogar O, Hansson EE (2019) Dyskinesia and FAB score predict future falling in Parkinson&#8217;s disease. Acta Neurol Scand 139:512&#8211;518<pub-id pub-id-type="pmid">30820932</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/ane.13084</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR39"><label>39.</label><citation-alternatives><element-citation id="ec-CR39" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lindholm</surname><given-names>B</given-names></name><name name-style="western"><surname>Hagell</surname><given-names>P</given-names></name><name name-style="western"><surname>Hansson</surname><given-names>O</given-names></name><name name-style="western"><surname>Nilsson</surname><given-names>MH</given-names></name></person-group><article-title>Prediction of falls and/or near falls in people with mild Parkinson's disease</article-title><source>PLoS ONE</source><year>2015</year><volume>10</volume><fpage>e0117018</fpage><pub-id pub-id-type="pmid">25635687</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1371/journal.pone.0117018</pub-id><pub-id pub-id-type="pmcid">PMC4311993</pub-id></element-citation><mixed-citation id="mc-CR39" publication-type="journal">Lindholm B, Hagell P, Hansson O, Nilsson MH (2015) Prediction of falls and/or near falls in people with mild Parkinson&#8217;s disease. PLoS ONE 10:e0117018<pub-id pub-id-type="pmid">25635687</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1371/journal.pone.0117018</pub-id><pub-id pub-id-type="pmcid">PMC4311993</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR40"><label>40.</label><citation-alternatives><element-citation id="ec-CR40" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lindholm</surname><given-names>B</given-names></name><name name-style="western"><surname>Nilsson</surname><given-names>MH</given-names></name><name name-style="western"><surname>Hansson</surname><given-names>O</given-names></name><name name-style="western"><surname>Hagell</surname><given-names>P</given-names></name></person-group><article-title>The clinical significance of 10-m walk test standardizations in Parkinson's disease</article-title><source>J Neurol</source><year>2018</year><volume>265</volume><fpage>1829</fpage><lpage>1835</lpage><pub-id pub-id-type="pmid">29876762</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s00415-018-8921-9</pub-id><pub-id pub-id-type="pmcid">PMC6060742</pub-id></element-citation><mixed-citation id="mc-CR40" publication-type="journal">Lindholm B, Nilsson MH, Hansson O, Hagell P (2018) The clinical significance of 10-m walk test standardizations in Parkinson&#8217;s disease. J Neurol 265:1829&#8211;1835<pub-id pub-id-type="pmid">29876762</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s00415-018-8921-9</pub-id><pub-id pub-id-type="pmcid">PMC6060742</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR41"><label>41.</label><citation-alternatives><element-citation id="ec-CR41" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lofgren</surname><given-names>N</given-names></name><name name-style="western"><surname>Benka Wallen</surname><given-names>M</given-names></name><name name-style="western"><surname>Sorjonen</surname><given-names>K</given-names></name><name name-style="western"><surname>Conradsson</surname><given-names>D</given-names></name><name name-style="western"><surname>Franzen</surname><given-names>E</given-names></name></person-group><article-title>Investigating the Mini-BESTest's construct validity in elderly with Parkinson's disease</article-title><source>Acta Neurol Scand</source><year>2017</year><volume>135</volume><fpage>614</fpage><lpage>621</lpage><pub-id pub-id-type="pmid">27417912</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/ane.12640</pub-id></element-citation><mixed-citation id="mc-CR41" publication-type="journal">Lofgren N, Benka Wallen M, Sorjonen K, Conradsson D, Franzen E (2017) Investigating the Mini-BESTest&#8217;s construct validity in elderly with Parkinson&#8217;s disease. Acta Neurol Scand 135:614&#8211;621<pub-id pub-id-type="pmid">27417912</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/ane.12640</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR42"><label>42.</label><citation-alternatives><element-citation id="ec-CR42" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lord</surname><given-names>S</given-names></name><name name-style="western"><surname>Baker</surname><given-names>K</given-names></name><name name-style="western"><surname>Nieuwboer</surname><given-names>A</given-names></name><name name-style="western"><surname>Burn</surname><given-names>D</given-names></name><name name-style="western"><surname>Rochester</surname><given-names>L</given-names></name></person-group><article-title>Gait variability in Parkinson's disease: an indicator of non-dopaminergic contributors to gait dysfunction?</article-title><source>J Neurol</source><year>2011</year><volume>258</volume><fpage>566</fpage><lpage>572</lpage><pub-id pub-id-type="pmid">21052710</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s00415-010-5789-8</pub-id></element-citation><mixed-citation id="mc-CR42" publication-type="journal">Lord S, Baker K, Nieuwboer A, Burn D, Rochester L (2011) Gait variability in Parkinson&#8217;s disease: an indicator of non-dopaminergic contributors to gait dysfunction? J Neurol 258:566&#8211;572<pub-id pub-id-type="pmid">21052710</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s00415-010-5789-8</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR43"><label>43.</label><citation-alternatives><element-citation id="ec-CR43" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mancini</surname><given-names>M</given-names></name><name name-style="western"><surname>Rocchi</surname><given-names>L</given-names></name><name name-style="western"><surname>Horak</surname><given-names>FB</given-names></name><name name-style="western"><surname>Chiari</surname><given-names>L</given-names></name></person-group><article-title>Effects of Parkinson's disease and levodopa on functional limits of stability</article-title><source>Clin Biomech (Bristol, Avon)</source><year>2008</year><volume>23</volume><fpage>450</fpage><lpage>458</lpage><pub-id pub-id-type="pmid">18155331</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.clinbiomech.2007.11.007</pub-id><pub-id pub-id-type="pmcid">PMC2776044</pub-id></element-citation><mixed-citation id="mc-CR43" publication-type="journal">Mancini M, Rocchi L, Horak FB, Chiari L (2008) Effects of Parkinson&#8217;s disease and levodopa on functional limits of stability. Clin Biomech (Bristol, Avon) 23:450&#8211;458<pub-id pub-id-type="pmid">18155331</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.clinbiomech.2007.11.007</pub-id><pub-id pub-id-type="pmcid">PMC2776044</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR44"><label>44.</label><citation-alternatives><element-citation id="ec-CR44" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Margolesky</surname><given-names>J</given-names></name><name name-style="western"><surname>Bette</surname><given-names>S</given-names></name><name name-style="western"><surname>Shpiner</surname><given-names>DS</given-names></name><name name-style="western"><surname>Jordan</surname><given-names>EA</given-names></name><name name-style="western"><surname>Dong</surname><given-names>C</given-names></name><name name-style="western"><surname>Rundek</surname><given-names>T</given-names></name><name name-style="western"><surname>Luca</surname><given-names>CC</given-names></name><name name-style="western"><surname>Moore</surname><given-names>H</given-names></name><name name-style="western"><surname>Singer</surname><given-names>C</given-names></name></person-group><article-title>Tandem gait abnormality in Parkinson disease: prevalence and implication as a predictor of fall risk</article-title><source>Parkinsonism Relat Disord</source><year>2019</year><volume>63</volume><fpage>83</fpage><lpage>87</lpage><pub-id pub-id-type="pmid">30824282</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.parkreldis.2019.02.034</pub-id></element-citation><mixed-citation id="mc-CR44" publication-type="journal">Margolesky J, Bette S, Shpiner DS, Jordan EA, Dong C, Rundek T, Luca CC, Moore H, Singer C (2019) Tandem gait abnormality in Parkinson disease: prevalence and implication as a predictor of fall risk. Parkinsonism Relat Disord 63:83&#8211;87<pub-id pub-id-type="pmid">30824282</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.parkreldis.2019.02.034</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR45"><label>45.</label><citation-alternatives><element-citation id="ec-CR45" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Margolesky</surname><given-names>J</given-names></name><name name-style="western"><surname>Singer</surname><given-names>C</given-names></name></person-group><article-title>How tandem gait stumbled into the neurological exam: a review</article-title><source>Neurol Sci</source><year>2018</year><volume>39</volume><fpage>23</fpage><lpage>29</lpage><pub-id pub-id-type="pmid">28894988</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s10072-017-3108-1</pub-id></element-citation><mixed-citation id="mc-CR45" publication-type="journal">Margolesky J, Singer C (2018) How tandem gait stumbled into the neurological exam: a review. Neurol Sci 39:23&#8211;29<pub-id pub-id-type="pmid">28894988</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s10072-017-3108-1</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR46"><label>46.</label><citation-alternatives><element-citation id="ec-CR46" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Montero-Odasso</surname><given-names>M</given-names></name><name name-style="western"><surname>van der Velde</surname><given-names>N</given-names></name><name name-style="western"><surname>Martin</surname><given-names>FC</given-names></name><name name-style="western"><surname>Petrovic</surname><given-names>M</given-names></name><name name-style="western"><surname>Tan</surname><given-names>MP</given-names></name><name name-style="western"><surname>Ryg</surname><given-names>J</given-names></name><name name-style="western"><surname>Aguilar-Navarro</surname><given-names>S</given-names></name><name name-style="western"><surname>Alexander</surname><given-names>NB</given-names></name><name name-style="western"><surname>Becker</surname><given-names>C</given-names></name><name name-style="western"><surname>Blain</surname><given-names>H</given-names></name><name name-style="western"><surname>Bourke</surname><given-names>R</given-names></name><name name-style="western"><surname>Cameron</surname><given-names>ID</given-names></name><name name-style="western"><surname>Camicioli</surname><given-names>R</given-names></name><name name-style="western"><surname>Clemson</surname><given-names>L</given-names></name><name name-style="western"><surname>Close</surname><given-names>J</given-names></name><name name-style="western"><surname>Delbaere</surname><given-names>K</given-names></name><name name-style="western"><surname>Duan</surname><given-names>L</given-names></name><name name-style="western"><surname>Duque</surname><given-names>G</given-names></name><name name-style="western"><surname>Dyer</surname><given-names>SM</given-names></name><name name-style="western"><surname>Freiberger</surname><given-names>E</given-names></name><name name-style="western"><surname>Ganz</surname><given-names>DA</given-names></name><name name-style="western"><surname>Gomez</surname><given-names>F</given-names></name><name name-style="western"><surname>Hausdorff</surname><given-names>JM</given-names></name><name name-style="western"><surname>Hogan</surname><given-names>DB</given-names></name><name name-style="western"><surname>Hunter</surname><given-names>SMW</given-names></name><name name-style="western"><surname>Jauregui</surname><given-names>JR</given-names></name><name name-style="western"><surname>Kamkar</surname><given-names>N</given-names></name><name name-style="western"><surname>Kenny</surname><given-names>RA</given-names></name><name name-style="western"><surname>Lamb</surname><given-names>SE</given-names></name><name name-style="western"><surname>Latham</surname><given-names>NK</given-names></name><name name-style="western"><surname>Lipsitz</surname><given-names>LA</given-names></name><name name-style="western"><surname>Liu-Ambrose</surname><given-names>T</given-names></name><name name-style="western"><surname>Logan</surname><given-names>P</given-names></name><name name-style="western"><surname>Lord</surname><given-names>SR</given-names></name><name name-style="western"><surname>Mallet</surname><given-names>L</given-names></name><name name-style="western"><surname>Marsh</surname><given-names>D</given-names></name><name name-style="western"><surname>Milisen</surname><given-names>K</given-names></name><name name-style="western"><surname>Moctezuma-Gallegos</surname><given-names>R</given-names></name><name name-style="western"><surname>Morris</surname><given-names>ME</given-names></name><name name-style="western"><surname>Nieuwboer</surname><given-names>A</given-names></name><name name-style="western"><surname>Perracini</surname><given-names>MR</given-names></name><name name-style="western"><surname>Pieruccini-Faria</surname><given-names>F</given-names></name><name name-style="western"><surname>Pighills</surname><given-names>A</given-names></name><name name-style="western"><surname>Said</surname><given-names>C</given-names></name><name name-style="western"><surname>Sejdic</surname><given-names>E</given-names></name><name name-style="western"><surname>Sherrington</surname><given-names>C</given-names></name><name name-style="western"><surname>Skelton</surname><given-names>DA</given-names></name><name name-style="western"><surname>Dsouza</surname><given-names>S</given-names></name><name name-style="western"><surname>Speechley</surname><given-names>M</given-names></name><name name-style="western"><surname>Stark</surname><given-names>S</given-names></name><name name-style="western"><surname>Todd</surname><given-names>C</given-names></name><name name-style="western"><surname>Troen</surname><given-names>BR</given-names></name><name name-style="western"><surname>van der Cammen</surname><given-names>T</given-names></name><name name-style="western"><surname>Verghese</surname><given-names>J</given-names></name><name name-style="western"><surname>Vlaeyen</surname><given-names>E</given-names></name><name name-style="western"><surname>Watt</surname><given-names>JA</given-names></name><name name-style="western"><surname>Masud</surname><given-names>T</given-names></name><collab>Task Force on Global Guidelines for Falls in Older A</collab></person-group><article-title>World guidelines for falls prevention and management for older adults: a global initiative</article-title><source>Age Ageing</source><year>2022</year><pub-id pub-id-type="doi">10.1093/ageing/afac205</pub-id><pub-id pub-id-type="pmid">36178003</pub-id><pub-id pub-id-type="pmcid">PMC9523684</pub-id></element-citation><mixed-citation id="mc-CR46" publication-type="journal">Montero-Odasso M, van der Velde N, Martin FC, Petrovic M, Tan MP, Ryg J, Aguilar-Navarro S, Alexander NB, Becker C, Blain H, Bourke R, Cameron ID, Camicioli R, Clemson L, Close J, Delbaere K, Duan L, Duque G, Dyer SM, Freiberger E, Ganz DA, Gomez F, Hausdorff JM, Hogan DB, Hunter SMW, Jauregui JR, Kamkar N, Kenny RA, Lamb SE, Latham NK, Lipsitz LA, Liu-Ambrose T, Logan P, Lord SR, Mallet L, Marsh D, Milisen K, Moctezuma-Gallegos R, Morris ME, Nieuwboer A, Perracini MR, Pieruccini-Faria F, Pighills A, Said C, Sejdic E, Sherrington C, Skelton DA, Dsouza S, Speechley M, Stark S, Todd C, Troen BR, van der Cammen T, Verghese J, Vlaeyen E, Watt JA, Masud T, Task Force on Global Guidelines for Falls in Older A (2022) World guidelines for falls prevention and management for older adults: a global initiative. Age Ageing. 10.1093/ageing/afac205<pub-id pub-id-type="pmid">36178003</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/ageing/afac205</pub-id><pub-id pub-id-type="pmcid">PMC9523684</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR47"><label>47.</label><citation-alternatives><element-citation id="ec-CR47" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Morris</surname><given-names>ME</given-names></name><name name-style="western"><surname>Menz</surname><given-names>HB</given-names></name><name name-style="western"><surname>McGinley</surname><given-names>JL</given-names></name><name name-style="western"><surname>Watts</surname><given-names>JJ</given-names></name><name name-style="western"><surname>Huxham</surname><given-names>FE</given-names></name><name name-style="western"><surname>Murphy</surname><given-names>AT</given-names></name><name name-style="western"><surname>Danoudis</surname><given-names>ME</given-names></name><name name-style="western"><surname>Iansek</surname><given-names>R</given-names></name></person-group><article-title>A randomized controlled trial to reduce falls in people with Parkinson's disease</article-title><source>Neurorehabil Neural Repair</source><year>2015</year><volume>29</volume><fpage>777</fpage><lpage>785</lpage><pub-id pub-id-type="pmid">25567121</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1177/1545968314565511</pub-id></element-citation><mixed-citation id="mc-CR47" publication-type="journal">Morris ME, Menz HB, McGinley JL, Watts JJ, Huxham FE, Murphy AT, Danoudis ME, Iansek R (2015) A randomized controlled trial to reduce falls in people with Parkinson&#8217;s disease. Neurorehabil Neural Repair 29:777&#8211;785<pub-id pub-id-type="pmid">25567121</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1177/1545968314565511</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR48"><label>48.</label><citation-alternatives><element-citation id="ec-CR48" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Morris</surname><given-names>ME</given-names></name><name name-style="western"><surname>Taylor</surname><given-names>NF</given-names></name><name name-style="western"><surname>Watts</surname><given-names>JJ</given-names></name><name name-style="western"><surname>Evans</surname><given-names>A</given-names></name><name name-style="western"><surname>Horne</surname><given-names>M</given-names></name><name name-style="western"><surname>Kempster</surname><given-names>P</given-names></name><name name-style="western"><surname>Danoudis</surname><given-names>M</given-names></name><name name-style="western"><surname>McGinley</surname><given-names>J</given-names></name><name name-style="western"><surname>Martin</surname><given-names>C</given-names></name><name name-style="western"><surname>Menz</surname><given-names>HB</given-names></name></person-group><article-title>A home program of strength training, movement strategy training and education did not prevent falls in people with Parkinson's disease: a randomised trial</article-title><source>J Physiother</source><year>2017</year><volume>63</volume><fpage>94</fpage><lpage>100</lpage><pub-id pub-id-type="pmid">28342682</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.jphys.2017.02.015</pub-id></element-citation><mixed-citation id="mc-CR48" publication-type="journal">Morris ME, Taylor NF, Watts JJ, Evans A, Horne M, Kempster P, Danoudis M, McGinley J, Martin C, Menz HB (2017) A home program of strength training, movement strategy training and education did not prevent falls in people with Parkinson&#8217;s disease: a randomised trial. J Physiother 63:94&#8211;100<pub-id pub-id-type="pmid">28342682</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.jphys.2017.02.015</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR49"><label>49.</label><citation-alternatives><element-citation id="ec-CR49" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Muller</surname><given-names>M</given-names></name><name name-style="western"><surname>Marusic</surname><given-names>U</given-names></name><name name-style="western"><surname>van Emde</surname><given-names>BM</given-names></name><name name-style="western"><surname>Weiss</surname><given-names>D</given-names></name><name name-style="western"><surname>Bohnen</surname><given-names>NI</given-names></name></person-group><article-title>Treatment options for postural instability and gait difficulties in Parkinson's disease</article-title><source>Expert Rev Neurother</source><year>2019</year><volume>19</volume><fpage>1229</fpage><lpage>1251</lpage><pub-id pub-id-type="pmid">31418599</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1080/14737175.2019.1656067</pub-id></element-citation><mixed-citation id="mc-CR49" publication-type="journal">Muller M, Marusic U, van Emde BM, Weiss D, Bohnen NI (2019) Treatment options for postural instability and gait difficulties in Parkinson&#8217;s disease. Expert Rev Neurother 19:1229&#8211;1251<pub-id pub-id-type="pmid">31418599</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1080/14737175.2019.1656067</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR50"><label>50.</label><citation-alternatives><element-citation id="ec-CR50" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nilsson</surname><given-names>MH</given-names></name><name name-style="western"><surname>Hagell</surname><given-names>P</given-names></name></person-group><article-title>Freezing of gait questionnaire: validity and reliability of the Swedish version</article-title><source>Acta Neurol Scand</source><year>2009</year><volume>120</volume><fpage>331</fpage><lpage>334</lpage><pub-id pub-id-type="pmid">19456303</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/j.1600-0404.2009.01175.x</pub-id></element-citation><mixed-citation id="mc-CR50" publication-type="journal">Nilsson MH, Hagell P (2009) Freezing of gait questionnaire: validity and reliability of the Swedish version. Acta Neurol Scand 120:331&#8211;334<pub-id pub-id-type="pmid">19456303</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/j.1600-0404.2009.01175.x</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR51"><label>51.</label><citation-alternatives><element-citation id="ec-CR51" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nonnekes</surname><given-names>J</given-names></name><name name-style="western"><surname>Goselink</surname><given-names>R</given-names></name><name name-style="western"><surname>Weerdesteyn</surname><given-names>V</given-names></name><name name-style="western"><surname>Bloem</surname><given-names>BR</given-names></name></person-group><article-title>The retropulsion test: a good evaluation of postural instability in Parkinson's disease?</article-title><source>J Parkinsons Dis</source><year>2015</year><volume>5</volume><fpage>43</fpage><lpage>47</lpage><pub-id pub-id-type="pmid">25613349</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3233/JPD-140514</pub-id></element-citation><mixed-citation id="mc-CR51" publication-type="journal">Nonnekes J, Goselink R, Weerdesteyn V, Bloem BR (2015) The retropulsion test: a good evaluation of postural instability in Parkinson&#8217;s disease? J Parkinsons Dis 5:43&#8211;47<pub-id pub-id-type="pmid">25613349</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3233/JPD-140514</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR52"><label>52.</label><citation-alternatives><element-citation id="ec-CR52" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pelicioni</surname><given-names>PHS</given-names></name><name name-style="western"><surname>Menant</surname><given-names>JC</given-names></name><name name-style="western"><surname>Henderson</surname><given-names>EJ</given-names></name><name name-style="western"><surname>Latt</surname><given-names>MD</given-names></name><name name-style="western"><surname>Brodie</surname><given-names>MA</given-names></name><name name-style="western"><surname>Lord</surname><given-names>SR</given-names></name></person-group><article-title>Mild and marked executive dysfunction and falls in people with Parkinson's disease</article-title><source>Braz J Phys Ther</source><year>2021</year><volume>25</volume><fpage>437</fpage><lpage>443</lpage><pub-id pub-id-type="pmid">33349526</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.bjpt.2020.11.005</pub-id><pub-id pub-id-type="pmcid">PMC8353304</pub-id></element-citation><mixed-citation id="mc-CR52" publication-type="journal">Pelicioni PHS, Menant JC, Henderson EJ, Latt MD, Brodie MA, Lord SR (2021) Mild and marked executive dysfunction and falls in people with Parkinson&#8217;s disease. Braz J Phys Ther 25:437&#8211;443<pub-id pub-id-type="pmid">33349526</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.bjpt.2020.11.005</pub-id><pub-id pub-id-type="pmcid">PMC8353304</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR53"><label>53.</label><citation-alternatives><element-citation id="ec-CR53" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Podsiadlo</surname><given-names>D</given-names></name><name name-style="western"><surname>Richardson</surname><given-names>S</given-names></name></person-group><article-title>The timed "Up &amp; Go": a test of basic functional mobility for frail elderly persons</article-title><source>J Am Geriatr Soc</source><year>1991</year><volume>39</volume><fpage>142</fpage><lpage>148</lpage><pub-id pub-id-type="pmid">1991946</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/j.1532-5415.1991.tb01616.x</pub-id></element-citation><mixed-citation id="mc-CR53" publication-type="journal">Podsiadlo D, Richardson S (1991) The timed &#8220;Up &amp; Go&#8221;: a test of basic functional mobility for frail elderly persons. J Am Geriatr Soc 39:142&#8211;148<pub-id pub-id-type="pmid">1991946</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/j.1532-5415.1991.tb01616.x</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR54"><label>54.</label><citation-alternatives><element-citation id="ec-CR54" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Postuma</surname><given-names>RB</given-names></name><name name-style="western"><surname>Berg</surname><given-names>D</given-names></name><name name-style="western"><surname>Stern</surname><given-names>M</given-names></name><name name-style="western"><surname>Poewe</surname><given-names>W</given-names></name><name name-style="western"><surname>Olanow</surname><given-names>CW</given-names></name><name name-style="western"><surname>Oertel</surname><given-names>W</given-names></name><name name-style="western"><surname>Obeso</surname><given-names>J</given-names></name><name name-style="western"><surname>Marek</surname><given-names>K</given-names></name><name name-style="western"><surname>Litvan</surname><given-names>I</given-names></name><name name-style="western"><surname>Lang</surname><given-names>AE</given-names></name><name name-style="western"><surname>Halliday</surname><given-names>G</given-names></name><name name-style="western"><surname>Goetz</surname><given-names>CG</given-names></name><name name-style="western"><surname>Gasser</surname><given-names>T</given-names></name><name name-style="western"><surname>Dubois</surname><given-names>B</given-names></name><name name-style="western"><surname>Chan</surname><given-names>P</given-names></name><name name-style="western"><surname>Bloem</surname><given-names>BR</given-names></name><name name-style="western"><surname>Adler</surname><given-names>CH</given-names></name><name name-style="western"><surname>Deuschl</surname><given-names>G</given-names></name></person-group><article-title>MDS clinical diagnostic criteria for Parkinson's disease</article-title><source>Mov Disord</source><year>2015</year><volume>30</volume><fpage>1591</fpage><lpage>1601</lpage><pub-id pub-id-type="pmid">26474316</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/mds.26424</pub-id></element-citation><mixed-citation id="mc-CR54" publication-type="journal">Postuma RB, Berg D, Stern M, Poewe W, Olanow CW, Oertel W, Obeso J, Marek K, Litvan I, Lang AE, Halliday G, Goetz CG, Gasser T, Dubois B, Chan P, Bloem BR, Adler CH, Deuschl G (2015) MDS clinical diagnostic criteria for Parkinson&#8217;s disease. Mov Disord 30:1591&#8211;1601<pub-id pub-id-type="pmid">26474316</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/mds.26424</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR55"><label>55.</label><citation-alternatives><element-citation id="ec-CR55" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Radder</surname><given-names>DLM</given-names></name><name name-style="western"><surname>Silva</surname><given-names>L</given-names></name><name name-style="western"><surname>de Lima</surname><given-names>A</given-names></name><name name-style="western"><surname>Domingos</surname><given-names>J</given-names></name><name name-style="western"><surname>Keus</surname><given-names>SHJ</given-names></name><name name-style="western"><surname>van Nimwegen</surname><given-names>M</given-names></name><name name-style="western"><surname>Bloem</surname><given-names>BR</given-names></name><name name-style="western"><surname>de Vries</surname><given-names>NM</given-names></name></person-group><article-title>Physiotherapy in Parkinson's disease: a meta-analysis of present treatment modalities</article-title><source>Neurorehabil Neural Repair</source><year>2020</year><volume>34</volume><fpage>871</fpage><lpage>880</lpage><pub-id pub-id-type="pmid">32917125</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1177/1545968320952799</pub-id><pub-id pub-id-type="pmcid">PMC7564288</pub-id></element-citation><mixed-citation id="mc-CR55" publication-type="journal">Radder DLM, Silva L, de Lima A, Domingos J, Keus SHJ, van Nimwegen M, Bloem BR, de Vries NM (2020) Physiotherapy in Parkinson&#8217;s disease: a meta-analysis of present treatment modalities. Neurorehabil Neural Repair 34:871&#8211;880<pub-id pub-id-type="pmid">32917125</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1177/1545968320952799</pub-id><pub-id pub-id-type="pmcid">PMC7564288</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR56"><label>56.</label><citation-alternatives><element-citation id="ec-CR56" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rusz</surname><given-names>J</given-names></name><name name-style="western"><surname>Krupicka</surname><given-names>R</given-names></name><name name-style="western"><surname>Viteckova</surname><given-names>S</given-names></name><name name-style="western"><surname>Tykalova</surname><given-names>T</given-names></name><name name-style="western"><surname>Novotny</surname><given-names>M</given-names></name><name name-style="western"><surname>Novak</surname><given-names>J</given-names></name><name name-style="western"><surname>Dusek</surname><given-names>P</given-names></name><name name-style="western"><surname>Ruzicka</surname><given-names>E</given-names></name></person-group><article-title>Speech and gait abnormalities in motor subtypes of de-novo Parkinson's disease</article-title><source>CNS Neurosci Ther</source><year>2023</year><volume>29</volume><fpage>2101</fpage><lpage>2110</lpage><pub-id pub-id-type="pmid">36942517</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/cns.14158</pub-id><pub-id pub-id-type="pmcid">PMC10352893</pub-id></element-citation><mixed-citation id="mc-CR56" publication-type="journal">Rusz J, Krupicka R, Viteckova S, Tykalova T, Novotny M, Novak J, Dusek P, Ruzicka E (2023) Speech and gait abnormalities in motor subtypes of de-novo Parkinson&#8217;s disease. CNS Neurosci Ther 29:2101&#8211;2110<pub-id pub-id-type="pmid">36942517</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/cns.14158</pub-id><pub-id pub-id-type="pmcid">PMC10352893</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR57"><label>57.</label><citation-alternatives><element-citation id="ec-CR57" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Stebbins</surname><given-names>GT</given-names></name><name name-style="western"><surname>Goetz</surname><given-names>CG</given-names></name><name name-style="western"><surname>Burn</surname><given-names>DJ</given-names></name><name name-style="western"><surname>Jankovic</surname><given-names>J</given-names></name><name name-style="western"><surname>Khoo</surname><given-names>TK</given-names></name><name name-style="western"><surname>Tilley</surname><given-names>BC</given-names></name></person-group><article-title>How to identify tremor dominant and postural instability/gait difficulty groups with the movement disorder society unified Parkinson's disease rating scale: comparison with the unified Parkinson's disease rating scale</article-title><source>Mov Disord</source><year>2013</year><volume>28</volume><fpage>668</fpage><lpage>670</lpage><pub-id pub-id-type="pmid">23408503</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/mds.25383</pub-id></element-citation><mixed-citation id="mc-CR57" publication-type="journal">Stebbins GT, Goetz CG, Burn DJ, Jankovic J, Khoo TK, Tilley BC (2013) How to identify tremor dominant and postural instability/gait difficulty groups with the movement disorder society unified Parkinson&#8217;s disease rating scale: comparison with the unified Parkinson&#8217;s disease rating scale. Mov Disord 28:668&#8211;670<pub-id pub-id-type="pmid">23408503</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/mds.25383</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR58"><label>58.</label><citation-alternatives><element-citation id="ec-CR58" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Stolze</surname><given-names>H</given-names></name><name name-style="western"><surname>Klebe</surname><given-names>S</given-names></name><name name-style="western"><surname>Petersen</surname><given-names>G</given-names></name><name name-style="western"><surname>Raethjen</surname><given-names>J</given-names></name><name name-style="western"><surname>Wenzelburger</surname><given-names>R</given-names></name><name name-style="western"><surname>Witt</surname><given-names>K</given-names></name><name name-style="western"><surname>Deuschl</surname><given-names>G</given-names></name></person-group><article-title>Typical features of cerebellar ataxic gait</article-title><source>J Neurol Neurosurg Psychiatry</source><year>2002</year><volume>73</volume><fpage>310</fpage><lpage>312</lpage><pub-id pub-id-type="pmid">12185166</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1136/jnnp.73.3.310</pub-id><pub-id pub-id-type="pmcid">PMC1738052</pub-id></element-citation><mixed-citation id="mc-CR58" publication-type="journal">Stolze H, Klebe S, Petersen G, Raethjen J, Wenzelburger R, Witt K, Deuschl G (2002) Typical features of cerebellar ataxic gait. J Neurol Neurosurg Psychiatry 73:310&#8211;312<pub-id pub-id-type="pmid">12185166</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1136/jnnp.73.3.310</pub-id><pub-id pub-id-type="pmcid">PMC1738052</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR59"><label>59.</label><citation-alternatives><element-citation id="ec-CR59" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tolosa</surname><given-names>E</given-names></name><name name-style="western"><surname>Garrido</surname><given-names>A</given-names></name><name name-style="western"><surname>Scholz</surname><given-names>SW</given-names></name><name name-style="western"><surname>Poewe</surname><given-names>W</given-names></name></person-group><article-title>Challenges in the diagnosis of Parkinson's disease</article-title><source>Lancet Neurol</source><year>2021</year><volume>20</volume><fpage>385</fpage><lpage>397</lpage><pub-id pub-id-type="pmid">33894193</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/S1474-4422(21)00030-2</pub-id><pub-id pub-id-type="pmcid">PMC8185633</pub-id></element-citation><mixed-citation id="mc-CR59" publication-type="journal">Tolosa E, Garrido A, Scholz SW, Poewe W (2021) Challenges in the diagnosis of Parkinson&#8217;s disease. Lancet Neurol 20:385&#8211;397<pub-id pub-id-type="pmid">33894193</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/S1474-4422(21)00030-2</pub-id><pub-id pub-id-type="pmcid">PMC8185633</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR60"><label>60.</label><citation-alternatives><element-citation id="ec-CR60" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tomlinson</surname><given-names>CL</given-names></name><name name-style="western"><surname>Stowe</surname><given-names>R</given-names></name><name name-style="western"><surname>Patel</surname><given-names>S</given-names></name><name name-style="western"><surname>Rick</surname><given-names>C</given-names></name><name name-style="western"><surname>Gray</surname><given-names>R</given-names></name><name name-style="western"><surname>Clarke</surname><given-names>CE</given-names></name></person-group><article-title>Systematic review of levodopa dose equivalency reporting in Parkinson's disease</article-title><source>Mov Disord</source><year>2010</year><volume>25</volume><fpage>2649</fpage><lpage>2653</lpage><pub-id pub-id-type="pmid">21069833</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/mds.23429</pub-id></element-citation><mixed-citation id="mc-CR60" publication-type="journal">Tomlinson CL, Stowe R, Patel S, Rick C, Gray R, Clarke CE (2010) Systematic review of levodopa dose equivalency reporting in Parkinson&#8217;s disease. Mov Disord 25:2649&#8211;2653<pub-id pub-id-type="pmid">21069833</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/mds.23429</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR61"><label>61.</label><citation-alternatives><element-citation id="ec-CR61" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Visser</surname><given-names>M</given-names></name><name name-style="western"><surname>Marinus</surname><given-names>J</given-names></name><name name-style="western"><surname>Bloem</surname><given-names>BR</given-names></name><name name-style="western"><surname>Kisjes</surname><given-names>H</given-names></name><name name-style="western"><surname>van den Berg</surname><given-names>BM</given-names></name><name name-style="western"><surname>van Hilten</surname><given-names>JJ</given-names></name></person-group><article-title>Clinical tests for the evaluation of postural instability in patients with Parkinson's disease</article-title><source>Arch Phys Med Rehabil</source><year>2003</year><volume>84</volume><fpage>1669</fpage><lpage>1674</lpage><pub-id pub-id-type="pmid">14639568</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1053/s0003-9993(03)00348-4</pub-id></element-citation><mixed-citation id="mc-CR61" publication-type="journal">Visser M, Marinus J, Bloem BR, Kisjes H, van den Berg BM, van Hilten JJ (2003) Clinical tests for the evaluation of postural instability in patients with Parkinson&#8217;s disease. Arch Phys Med Rehabil 84:1669&#8211;1674<pub-id pub-id-type="pmid">14639568</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1053/s0003-9993(03)00348-4</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR62"><label>62.</label><citation-alternatives><element-citation id="ec-CR62" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Warden</surname><given-names>MN</given-names></name><name name-style="western"><surname>Searles Nielsen</surname><given-names>S</given-names></name><name name-style="western"><surname>Camacho-Soto</surname><given-names>A</given-names></name><name name-style="western"><surname>Garnett</surname><given-names>R</given-names></name><name name-style="western"><surname>Racette</surname><given-names>BA</given-names></name></person-group><article-title>A comparison of prediction approaches for identifying prodromal Parkinson disease</article-title><source>PLoS ONE</source><year>2021</year><volume>16</volume><fpage>e0256592</fpage><pub-id pub-id-type="pmid">34437600</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1371/journal.pone.0256592</pub-id><pub-id pub-id-type="pmcid">PMC8389479</pub-id></element-citation><mixed-citation id="mc-CR62" publication-type="journal">Warden MN, Searles Nielsen S, Camacho-Soto A, Garnett R, Racette BA (2021) A comparison of prediction approaches for identifying prodromal Parkinson disease. PLoS ONE 16:e0256592<pub-id pub-id-type="pmid">34437600</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1371/journal.pone.0256592</pub-id><pub-id pub-id-type="pmcid">PMC8389479</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR63"><label>63.</label><citation-alternatives><element-citation id="ec-CR63" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wilson</surname><given-names>J</given-names></name><name name-style="western"><surname>Alcock</surname><given-names>L</given-names></name><name name-style="western"><surname>Yarnall</surname><given-names>AJ</given-names></name><name name-style="western"><surname>Lord</surname><given-names>S</given-names></name><name name-style="western"><surname>Lawson</surname><given-names>RA</given-names></name><name name-style="western"><surname>Morris</surname><given-names>R</given-names></name><name name-style="western"><surname>Taylor</surname><given-names>JP</given-names></name><name name-style="western"><surname>Burn</surname><given-names>DJ</given-names></name><name name-style="western"><surname>Rochester</surname><given-names>L</given-names></name><name name-style="western"><surname>Galna</surname><given-names>B</given-names></name></person-group><article-title>Gait progression over 6 years in Parkinson's disease: effects of age, medication, and pathology</article-title><source>Front Aging Neurosci</source><year>2020</year><volume>12</volume><fpage>577435</fpage><pub-id pub-id-type="pmid">33192470</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3389/fnagi.2020.577435</pub-id><pub-id pub-id-type="pmcid">PMC7593770</pub-id></element-citation><mixed-citation id="mc-CR63" publication-type="journal">Wilson J, Alcock L, Yarnall AJ, Lord S, Lawson RA, Morris R, Taylor JP, Burn DJ, Rochester L, Galna B (2020) Gait progression over 6 years in Parkinson&#8217;s disease: effects of age, medication, and pathology. Front Aging Neurosci 12:577435<pub-id pub-id-type="pmid">33192470</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3389/fnagi.2020.577435</pub-id><pub-id pub-id-type="pmcid">PMC7593770</pub-id></mixed-citation></citation-alternatives></ref></ref-list></back></article></pmc-articleset>